JP6182526B2 - Sugar chain antigen extraction kit and detection kit - Google Patents

Sugar chain antigen extraction kit and detection kit Download PDF

Info

Publication number
JP6182526B2
JP6182526B2 JP2014519996A JP2014519996A JP6182526B2 JP 6182526 B2 JP6182526 B2 JP 6182526B2 JP 2014519996 A JP2014519996 A JP 2014519996A JP 2014519996 A JP2014519996 A JP 2014519996A JP 6182526 B2 JP6182526 B2 JP 6182526B2
Authority
JP
Japan
Prior art keywords
sample
container
extract
specimen
swab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014519996A
Other languages
Japanese (ja)
Other versions
JPWO2013183621A1 (en
Inventor
洋久 松下
洋久 松下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nichirei Biosciences Inc
Original Assignee
Nichirei Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nichirei Biosciences Inc filed Critical Nichirei Biosciences Inc
Priority to JP2014519996A priority Critical patent/JP6182526B2/en
Publication of JPWO2013183621A1 publication Critical patent/JPWO2013183621A1/en
Application granted granted Critical
Publication of JP6182526B2 publication Critical patent/JP6182526B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5029Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures using swabs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/38Caps; Covers; Plugs; Pouring means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M33/00Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
    • C12M33/02Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by impregnation, e.g. using swabs or loops
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4055Concentrating samples by solubility techniques
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14Process control and prevention of errors
    • B01L2200/141Preventing contamination, tampering
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/04Closures and closing means
    • B01L2300/041Connecting closures to device or container
    • B01L2300/042Caps; Plugs
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/04Closures and closing means
    • B01L2300/041Connecting closures to device or container
    • B01L2300/044Connecting closures to device or container pierceable, e.g. films, membranes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4055Concentrating samples by solubility techniques
    • G01N2001/4061Solvent extraction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Sustainable Development (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

本発明は、糖鎖抗原抽出キット及び検出キットに関し、例えば被検者の咽頭から採取した咽頭ぬぐい液中にA群β溶血連鎖球菌(streptococcus pyogenes)抗原が存在するか否かを検査する際に適用して好適なものである。   The present invention relates to a sugar chain antigen extraction kit and a detection kit. For example, when examining whether or not a group A β streptococcus pyogenes antigen is present in a pharyngeal swab collected from the pharynx of a subject. It is suitable for application.

従来、A群β溶血連鎖球菌抗原の存在の有無を検査する検出キットとしては、使用直前に2種の薬液を混合して用いるA群β溶血連鎖球菌抗原キットが知られている(例えば、非特許文献1参照)。実際上、このA群β溶血連鎖球菌抗原キットは、例えば、2[mol/L]亜硝酸ナトリウムを成分とする薬液Aが入った第1ボトルと、0.2[mol/L]酢酸を成分とする薬液Bが入った第2ボトルと、試験管形状の抽出用チューブと、被検者の炎症部分である咽頭から検体を採取する綿棒と、陽性又は陰性を判定するテストストリップとから構成されている。   Conventionally, as a detection kit for examining the presence or absence of a group A β-hemolytic streptococcal antigen, a group A β-hemolytic streptococcal antigen kit used by mixing two kinds of chemicals immediately before use is known (for example, non- Patent Document 1). Actually, this group A β-hemolytic streptococcal antigen kit is composed of, for example, a first bottle containing a chemical solution A containing 2 [mol / L] sodium nitrite and 0.2 [mol / L] acetic acid as components. It is composed of a second bottle containing medicinal solution B, a test tube-shaped extraction tube, a cotton swab for collecting a specimen from the pharynx, which is an inflamed part of the subject, and a test strip for determining positive or negative. .

このA群β溶血連鎖球菌抗原キットでは、多糖抗原たるA群β溶血連鎖球菌抗原を菌体から遊離させて抽出するために、亜硝酸を用いており、使用直前に亜硝酸を含んだ混合薬液を生成する。実際上、このA群β溶血連鎖球菌抗原キットでは、使用する直前に、図9Aに示すように、第1ボトル101内の薬液Aと、第2ボトル102内の薬液Bとをそれぞれ数滴、抽出用チューブ100に滴下し、検体抽出液として亜硝酸を成分とした混合薬液を生成する。   In this group A β-hemolytic streptococcal antigen kit, nitrite is used in order to release and extract the group A β-hemolytic streptococcal antigen, which is a polysaccharide antigen, from the cells, and a mixed drug solution containing nitrite immediately before use Is generated. Actually, in this group A β-hemolytic streptococcal antigen kit, just before use, as shown in FIG. 9A, several drops of the drug solution A in the first bottle 101 and the drug solution B in the second bottle 102, It is dripped at the tube 100 for extraction, and the mixed chemical | medical solution which uses nitrous acid as a component is produced | generated as a specimen extract.

ここで、図9Bに示すように、抽出用チューブ100は、使用者が片方の指Fにて摘める外形形状を有しており、当該指Fで把持された状態で、他方の指にて綿棒105を把持させることができる。この場合、使用者は、被検者の咽頭等の炎症部分を、先端綿球部105aにてぬぐって咽頭ぬぐい液を検体として採取した綿棒105を用意する。次いで、検体を採取した綿棒105の先端綿球部105aを、抽出用チューブ100内の混合薬液に浸し、親指及び人差し指の腹にて抽出用チューブ100を僅かに潰して先端綿球部105aを抽出用チューブ100の両側壁にて軽く挟み、先端綿球部105aにて混合薬液をかき回した後、約1分程度放置する。   Here, as shown in FIG. 9B, the extraction tube 100 has an outer shape that can be picked by the user with one finger F, and in the state of being gripped by the finger F, The swab 105 can be gripped. In this case, the user prepares a cotton swab 105 in which an inflamed part such as the pharynx of the subject is wiped with a tip cotton ball part 105a and a throat swab is collected as a specimen. Next, the tip cotton ball portion 105a of the cotton swab 105 from which the specimen was collected is immersed in the mixed chemical solution in the extraction tube 100, and the tip cotton ball portion 105a is extracted by slightly crushing the extraction tube 100 with the abdomen of the thumb and index finger. The tube 100 is lightly sandwiched between both side walls, and the mixed drug solution is swirled with the tip cotton ball 105a, and then left for about 1 minute.

次いで、図10Aに示すように、使用者は、親指及び人差し指の腹にて抽出用チューブ100を潰し、抽出用チューブ100内の先端綿球部105aを、当該抽出用チューブ100の側壁を介して強く摘み、先端綿球部105aに染み込んだ検体や混合薬液を絞り出しながら、綿棒105を抽出用チューブ100から取り出す。このようにして、抽出用チューブ100内には、先端綿球部105aにて採取した検体が混合薬液中に放出された試液が生成され得る。   Next, as shown in FIG. 10A, the user crushes the extraction tube 100 with the thumb and forefinger, and the tip cotton ball portion 105a in the extraction tube 100 passes through the side wall of the extraction tube 100. The cotton swab 105 is taken out from the extraction tube 100 while strongly picking and squeezing out the specimen and the mixed chemical liquid soaked into the tip cotton ball part 105a. In this way, in the extraction tube 100, a test solution can be generated in which the sample collected at the tip cotton ball part 105a is released into the mixed drug solution.

ここで、混合薬液を入れる抽出用チューブ100は、アクリル樹脂のような柔軟性のある軟質材料により形成されていることから、使用者が指Fで摘み所定の把持力を与えることで、対向する側壁が潰れて互いに密着するまで変形可能に構成されている。これにより、抽出用チューブ100は、抽出用チューブ100内に入れられた綿棒105の先端綿球部105aを、側壁を介して外部から確実に摘めるとともに、側壁を介して当該先端綿球部105aを指にて強く摘んだ状態で擦る「しごき作業」を行え、このしごき作業によって当該先端綿球部105aに染み込んだ検体や試液等を確実に絞り出せるように構成されている。   Here, since the extraction tube 100 into which the mixed chemical solution is put is formed of a flexible soft material such as an acrylic resin, the user grips it with a finger F to give a predetermined gripping force. It is configured to be deformable until the side walls are crushed and come into close contact with each other. As a result, the extraction tube 100 can securely grip the tip cotton ball portion 105a of the cotton swab 105 placed in the extraction tube 100 from the outside through the side wall, and the tip cotton ball portion 105a through the side wall. A “squeezing operation” can be performed by rubbing in a state where the finger is strongly picked with a finger, and the specimen, the test solution, etc. soaked into the tip cotton ball portion 105a can be surely squeezed out by this ironing operation.

最後に、図10Bに示すように、抽出用チューブ100内の試液S2に、テストストリップ110の判定部を浸した後、所定時間経過後に、判定部における抗原抗体反応によるライン出現の有無を目視にて確認し、当該ライン出現の有無を基に、試液S2内にA群β溶血連鎖球菌抗原が存在するか否かを判定し得るようになされている。   Finally, as shown in FIG. 10B, after the determination unit of the test strip 110 is immersed in the test solution S2 in the extraction tube 100, the presence or absence of a line due to an antigen-antibody reaction in the determination unit is visually observed after a predetermined time has elapsed. Based on the presence or absence of the appearance of the line, it can be determined whether or not the group A β-hemolytic streptococcal antigen is present in the test solution S2.

「スタットチェックTMストレップA-II」、[online]、平成24年4月26日検索、インターネット(URL:http://www.info.pmda.go.jp/downfiles/ivd/PDF/531143_22100AMX02226000_A_01_01.pdf)"Statcheck TM Strep A-II", [online], search on April 26, 2012, Internet (URL: http://www.info.pmda.go.jp/downfiles/ivd/PDF/531143_22100AMX02226000_A_01_01.pdf )

しかしながら、かかる構成でなるA群β溶血連鎖球菌抗原キットにおいて、抽出用チューブ100内に生成された混合薬液は、不安定な亜硝酸を含んでいるため、事前に混合して抽出用チューブ100に保管しておくと変質してしまい、検査に用いることができなくなることから、医療現場にて使用直前にその都度混合せざるを得ず、用時調製する必要があった。そのため、使用者によっては、薬液Aと薬液Bの混合割合を誤ってしまう虞もある。その場合には、陰性にも関わらず偽陽性となってしまったり、また、陽性にも関わらず偽陰性となってしまうこともあるため、正しい診断結果が得られない場合もあるという問題があった。   However, in the group A β-hemolytic streptococcal antigen kit having such a configuration, the mixed drug solution generated in the extraction tube 100 contains unstable nitrous acid. If stored, it will be altered and cannot be used for testing. Therefore, it must be mixed immediately before use in the medical field, and it must be prepared at the time of use. Therefore, depending on the user, the mixing ratio of the chemical liquid A and the chemical liquid B may be wrong. In that case, there is a problem that a false diagnosis may not be obtained because a false positive may be obtained despite a negative, or a false negative may be obtained despite a positive. It was.

その一方、このような誤った用時調製の問題点を解決するため、従来のA群β溶血連鎖球菌抗原キットとして、例えば所定量の薬液Bが予め入った外側ボトル中に、所定量の薬液Aが予め入ったアンプルを収納したアンプル収納型ボトルを用いたものも知られている。この種のA群β溶血連鎖球菌抗原キットでは、不使用時、薬液Aと薬液Bとが外側ボトル内にてアンプルにより隔離された状態にあるものの、使用直前に、柔軟性のある軟質材料からなる外側ボトルを指で強く摘んでアンプルを潰すことにより、中のアンプルを破壊し、アンプル内の所定量の薬液Aを、外側ボトル内の薬液Bと混合させることで、薬液Aと薬液Bとが最適な混合比率で混合された混合薬液を生成し得る。   On the other hand, as a conventional group A β-hemolytic streptococcal antigen kit, for example, a predetermined amount of chemical solution is placed in an outer bottle preliminarily filled with a predetermined amount of chemical solution B in order to solve the problem of such erroneous preparation at the time of use. There is also known an ampoule storage type bottle in which an ampule containing A is stored in advance. In this type of group A β-hemolytic streptococcal antigen kit, when not in use, the drug solution A and the drug solution B are separated by an ampule in the outer bottle, but immediately before use, from a flexible soft material The ampule is crushed by strongly picking the outer bottle with a finger to destroy the ampule, and a predetermined amount of the medicinal solution A in the ampule is mixed with the medicinal solution B in the outer bottle. Can produce a mixed chemical mixed at an optimal mixing ratio.

しかしながら、この種のA群β溶血連鎖球菌抗原キットでも、薬液Aと薬液Bとを最適な混合比率で混合させた混合薬液を生成できるものの、使用直前に混合薬液を用時調製する必要があることに変わりなく、その分、使用者にとって手間がかかるという問題があった。また、使用者が誤って外側ボトル内のアンプルを破壊してしまい薬液Aと薬液Bとを混合させてしまったり、或いは、A群β溶血連鎖球菌抗原キットを搬送中に、何らかの原因でアンプル収納型ボトルに衝撃が加えられ、外側ボトル内のアンプルが破壊されてしまうと、使用者が意図しないタイミングで薬液Aと薬液Bとが混合されてしまう。   However, this type of group A β-hemolytic streptococcal antigen kit can produce a mixed drug solution in which the drug solution A and the drug solution B are mixed at an optimum mixing ratio, but it is necessary to prepare a mixed drug solution immediately before use. In fact, there was a problem that it took time and effort for the user. In addition, the ampoule in the outer bottle may be accidentally destroyed by the user and mixed with drug solution A and drug solution B, or the ampoule is stored for some reason while transporting the group A β-hemolytic streptococcal antigen kit. When an impact is applied to the mold bottle and the ampule in the outer bottle is destroyed, the chemical liquid A and the chemical liquid B are mixed at a timing not intended by the user.

このように、薬液Aと薬液Bとが意図しないタイミングで混合されてしまった場合には、外側ボトル内にて生成された混合薬液が時間経過とともに変質してしまい、その後、検査に用いることができないことから、このような誤った調製が行われないことが望まれている。   As described above, when the chemical liquid A and the chemical liquid B are mixed at an unintended timing, the mixed chemical liquid generated in the outer bottle is deteriorated with the passage of time, and then used for the inspection. It is hoped that such an incorrect preparation will not occur because it is not possible.

また、後者のアンプル収納型ボトルは、外側ボトル内にアンプルを収容させた複雑な構成を有し、かつそれぞれ薬液A及び薬液Bを個別に1回使用する分量に分注し、それを外側ボトル及びアンプルにそれぞれ入れる必要があることから、その分、手間がかかり製造コストが増大してしまうという問題があった。   The latter ampoule-storing bottle has a complicated configuration in which the ampoule is accommodated in the outer bottle, and each of the chemical solution A and the chemical solution B is dispensed into individual quantities for use once, and is then dispensed into the outer bottle. In addition, since it is necessary to put in each ampule, there is a problem that it takes time and manufacturing cost increases.

そこで、本発明は以上の点を考慮してなされたもので、用時調製を不要とし、また簡易な構成で製造コストを低減し得る糖鎖抗原抽出キット及び検出キットを提案することを目的とする。   Therefore, the present invention has been made in consideration of the above points, and aims to propose a sugar chain antigen extraction kit and a detection kit that do not require preparation at the time of use and that can reduce the manufacturing cost with a simple configuration. To do.

かかる課題を解決するため本発明の請求項1は、気密性を維持した容器部内に、亜硝酸を含む検体抽出液が予め封入された気密容器と、被検者から検体を採取する採取部を備え、前記採取部にて前記検体を採取した後、該採取部が前記検体抽出液に浸され、前記採取部から前記検体抽出液に前記検体を抽出させる検体採取用スワブとを備え、前記採取部は、開封された前記気密容器内で前記検体抽出液に浸され、前記被検者から前記検体を採取した際、前記検体が前記採取部の内部にまで浸透することなく、少なくとも毛細管現象又は表面張力のいずれか一方により前記検体を付着させる表面を有し、かつ、前記検体抽出液に浸された後、前記容器部から取り出される際、前記容器部の内壁に押し当てられるだけで、前記検体を前記検体抽出液に放出することを特徴とする糖鎖抗原抽出キットである。本発明の請求項2は、気密性を維持した容器部内に、亜硝酸を含む検体抽出液が予め封入された気密容器と、被検者から検体を採取する採取部を備え、前記採取部にて前記検体を採取した後、該採取部が前記検体抽出液に浸され、前記採取部から前記検体抽出液に前記検体を抽出させる検体採取用スワブとを備え、前記採取部は、開封された前記気密容器内で前記検体抽出液に浸され、前記検体採取用スワブが、立毛表層部により覆われた前記採取部を備えたフログドスワブ、表面に多孔質を有したスポンジからなる前記採取部を備えたスポンジスワブ、又は、ループ状に折り曲げられO状に形成された前記採取部を備えるループであることを特徴とする糖鎖抗原抽出キットである。 In order to solve this problem, claim 1 of the present invention includes an airtight container in which a specimen extract containing nitrous acid is sealed in a container part that maintains airtightness, and a collection part that collects a specimen from a subject. wherein said after collecting the specimen by collecting section, the collecting portion is immersed in the specimen extract, and a swab for specimen collection for extracting the analyte in the sample extract from the collecting unit, the collecting The portion is immersed in the sample extract in the opened airtight container, and when the sample is collected from the subject, the sample does not penetrate into the inside of the collection unit, at least capillary action or It has a surface to which the specimen is attached by any one of the surface tensions, and after being immersed in the specimen extract, it is simply pressed against the inner wall of the container section when taken out from the container section. Sample extraction A carbohydrate antigen extraction kit characterized that you release the. Claim 2 of the present invention includes an airtight container in which a specimen extract containing nitrous acid is sealed in advance in a container part that maintains airtightness, and a collection part that collects a specimen from a subject. A sample collection swab for extracting the sample from the collection unit into the sample extraction solution, the collection unit being unsealed. The sample collection swab soaked in the sample extract in the airtight container includes a frog swab having the collection unit covered with a napped surface layer portion, and the collection unit made of a sponge having a porous surface. This is a sugar chain antigen extraction kit, characterized in that it is a sponge swab or a loop comprising the sampling part bent in a loop shape and formed in an O shape.

また、本発明では、上記気密容器として、亜硝酸ナトリウム水溶液と、酸性溶液とを混合して予め生成された不安定な亜硝酸を含む検体抽出液が、気密性を維持した容器部内に予め封入された気密容器を備えるようにした。   Further, in the present invention, as the above airtight container, a specimen extract containing unstable nitrous acid generated in advance by mixing an aqueous solution of sodium nitrite and an acidic solution is enclosed in advance in a container part that maintains airtightness. An airtight container was provided.

また、本発明では、気密容器内の所定部位に採取部を押し付けることで前記採取部から前記検体抽出液に前記検体を抽出させる検体採取用スワブを備えるようにした。   In the present invention, the sample collection swab is provided to extract the sample from the collection unit to the sample extract by pressing the collection unit against a predetermined site in the airtight container.

また、請求項7は、請求項1〜6のうちいずれか1項記載の糖鎖抗原抽出キットと、A群β溶血連鎖球菌を検出するためのイムノクロマト法用テストストリップとを備えることを特徴とする検出キットである。   In addition, a seventh aspect includes the sugar chain antigen extraction kit according to any one of the first to sixth aspects and an immunochromatographic test strip for detecting group A β-hemolytic streptococci. Detection kit.

本発明の請求項1又は2によれば、気密性を維持した気密容器に、予め調製した亜硝酸を含む検体抽出液を封入するようにしたことで、従来不可能であった亜硝酸を含ませた状態での検体抽出液の長期保存を可能とし、その結果、医療現場での用時調製を不要にできるとともに、誤った調製をも防止でき、さらに気密容器に1液だけが封入した簡易な構成となる分、製造コストも低減できる。
According to claim 1 or 2 of the present invention, a specimen extract containing nitrous acid prepared in advance is sealed in an airtight container that maintains airtightness. The specimen extract can be stored for a long time without any need for preparation at the medical site. In addition, incorrect preparation can be prevented and only one solution is sealed in an airtight container. As a result, the manufacturing cost can be reduced.

本発明による糖鎖抗原抽出キットの全体構成を示す概略図である。It is the schematic which shows the whole structure of the sugar_chain | carbohydrate antigen extraction kit by this invention. 気密容器の詳細構成を示す概略図である。It is the schematic which shows the detailed structure of an airtight container. 気密容器の容器部に検体採取用スワブを挿入したときの様子を示す概略図である。It is the schematic which shows a mode when the sample collection swab is inserted in the container part of an airtight container. 検体抽出液調製後の安定性を示すグラフである。It is a graph which shows stability after specimen extract preparation. 他の実施の形態による気密容器の構成を示す概略図である。It is the schematic which shows the structure of the airtight container by other embodiment. 図5に示す気密容器の詳細構成を示す概略図である。It is the schematic which shows the detailed structure of the airtight container shown in FIG. 他の実施の形態によるキャップを設けた気密容器の側断面構成を示す断面図である。It is sectional drawing which shows the side cross-section structure of the airtight container provided with the cap by other embodiment. 粉状体を封入した気密容器の構成を示す概略図である。It is the schematic which shows the structure of the airtight container which enclosed the powdery body. 従来のA群β溶血連鎖球菌抗原キットの使用方法の説明(1)に供する概略図である。It is the schematic where it uses for description (1) of the usage method of the conventional group A beta hemolytic streptococcal antigen kit. 従来のA群β溶血連鎖球菌抗原キットの使用方法の説明(2)に供する概略図である。It is the schematic where it uses for description (2) of the usage method of the conventional group A beta-hemolytic streptococcus antigen kit.

1 糖鎖抗原抽出キット
2 検体採取用スワブ
3,20,30,50 気密容器
6 採取部
7 立毛表層部(表面)
10,21,32 キャップ
11,31 容器部
18,24 パッキン
51 粉状体(しごき部材)
1 Sugar chain antigen extraction kit
2 Sample collection swab
3,20,30,50 Airtight container
6 Collection unit
7 Napped surface layer (surface)
10,21,32 cap
11,31 Container section
18,24 packing
51 Powdery body

以下図面に基づいて本発明の実施の形態を詳述する。   Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.

(1)糖鎖抗原抽出キットの全体構成
図1において、1は本発明による糖鎖抗原抽出キットを示し、キャップ10及び容器部11により気密空間が形成されている気密容器3と、被検者から検体を採取し、当該検体を気密容器3内にて検体抽出液Sに抽出させる検体採取用スワブ2とを備え、封入液体として亜硝酸を含む検体抽出液Sが気密容器3内に封入されている。
(1) Whole structure of sugar chain antigen extraction kit In FIG. 1, 1 shows the sugar chain antigen extraction kit by this invention, the airtight container 3 in which airtight space is formed with the cap 10 and the container part 11, and a subject. And a sample collection swab 2 for extracting the sample to the sample extract S in the airtight container 3, and the sample extract S containing nitrous acid is enclosed in the airtight container 3 as an enclosed liquid ing.

この実施の形態の場合、糖鎖抗原抽出キット1は、被検者から採取した検体を、気密容器3内の検体抽出液Sに抽出させて試液を生成した後、図示しないテストストリップの判定部をこの試液に浸し、判定部における抗原抗体反応によるライン出現の有無により、試液内にA群β溶血連鎖球菌抗原(検出対象物)が存在しているか否かを判定し得るようになされている。   In this embodiment, the sugar chain antigen extraction kit 1 generates a test solution by extracting the sample collected from the subject into the sample extract S in the airtight container 3, and then a test strip determination unit (not shown). Is immersed in this test solution, and whether or not the group A β-hemolytic streptococcal antigen (detection target) is present in the test solution can be determined by the presence or absence of a line due to the antigen-antibody reaction in the determination unit. .

ここで、糖鎖抗原抽出キット1を構成する検体採取用スワブ2は、所定長さでなる棒状の軸部5と、軸部5の先端に設けられ、例えば断面楕円状に形成された採取部6とを備えている。採取部6は、立毛体がブラシ状に密集した立毛表層部7により覆われており、例えばある液体に触れた際、当該液体が採取部6の内部にまで浸透することなく、毛細管現象や表面張力により立毛表層部7に留まり吸着し得るようになされている。   Here, the sample collection swab 2 constituting the sugar chain antigen extraction kit 1 is provided with a rod-shaped shaft portion 5 having a predetermined length, and a collection portion provided at the tip of the shaft portion 5, for example, having an elliptical cross section. 6 and. The collection unit 6 is covered with a napped surface layer portion 7 in which napped bodies are densely packed in a brush shape.For example, when a certain liquid is touched, the liquid does not penetrate into the inside of the collection unit 6, and capillary action or surface The tension is applied to the napped surface layer portion 7 by tension.

これにより、検体採取用スワブ2は、採取部6にて例えば被検者の炎症部分たる咽頭をぬぐうと、咽頭から得られる検体が採取部6の内部にまで浸透することなく、毛細管現象や表面張力によってその表面の立毛表層部7に吸着し得る。また、この採取部6は、立毛表層部7に検体が吸着された状態で、容器部11内の検体抽出液Sに浸されると、立毛表層部7に吸着していた検体が検体抽出液S中に放出され得るようになされている。   Thus, when the sample collection swab 2 wipes, for example, the pharynx, which is an inflamed part of the subject, in the collection unit 6, the sample obtained from the pharynx does not penetrate into the collection unit 6, and capillary action or surface It can be adsorbed to the napped surface layer portion 7 on the surface by tension. Further, when the sample is adsorbed on the napped surface layer portion 7 and immersed in the sample extract S in the container unit 11 in a state where the sample is adsorbed on the napped surface layer portion 7, the sample adsorbed on the napped surface layer portion 7 It can be released into S.

また、この検体採取用スワブ2は、当該検体採取用スワブ2を容器部11から引き出す際に、立毛表層部7をしごく等して外力を与えなくとも、容器部11の内壁に立毛表層部7を単に押し当てるだけで、毛細管現象や表面張力により立毛表層部7に留まっていた検体や検体抽出液Sが内壁に沿って流下し、立毛表層部7から検体や検体抽出液Sを除去し得るようになされている。   Further, the sample collection swab 2 can be provided on the inner wall of the container portion 11 without applying external force by squeezing the raised surface layer portion 7 when the sample collection swab 2 is pulled out from the container portion 11. The specimen and specimen extract S staying on the napped surface layer 7 due to capillary action and surface tension can flow down along the inner wall, and the specimen and specimen extract S can be removed from the napped surface layer 7 simply by pressing It is made like that.

一方、気密容器3は、図2に示すように、一端に開口部13を有した瓶状の容器部11と、開口部13の周縁側壁部に螺着することで開口部13を閉塞して容器部11内の気密性を維持させるキャップ10とから構成されており、これら容器部11及びキャップ10により気密性が保持された気密空間内に所定量の検体抽出液Sが封入されている。   On the other hand, as shown in FIG. 2, the airtight container 3 closes the opening 13 by screwing the bottle-shaped container 11 having the opening 13 at one end and the peripheral side wall of the opening 13. A cap 10 that maintains hermeticity in the container part 11 is configured, and a predetermined amount of the sample extract S is sealed in an airtight space in which the hermeticity is maintained by the container part 11 and the cap 10.

ここで、この実施の形態の場合、気密容器3に封入されている検体抽出液Sは、多糖抗原たるA群β溶血連鎖球菌抗原を菌体から遊離させて抽出するための亜硝酸が含まれており、例えば亜硝酸ナトリウム水溶液と、酢酸や塩酸等の酸を含む酸性溶液との2液が混合されて亜硝酸が生成され、気密性を維持した気密容器3内に封入されることで、検体抽出液S内に亜硝酸が発生している状態が維持されている。このように、この気密容器3では、キャップ10を開放させるまで気密性が維持された状態で検体抽出液Sを保持し続けることで、例えば6か月以上、好ましくは12か月以上の長期間に亘って、亜硝酸が含まれた状態を維持し、検体抽出液Sが持つA群β溶血連鎖球菌抗原の抽出能力を保持し得るようになされている。   Here, in the case of this embodiment, the specimen extract S sealed in the airtight container 3 contains nitrite for extracting the group A β-hemolytic streptococcal antigen, which is a polysaccharide antigen, from the cells. For example, by mixing two solutions of an aqueous solution of sodium nitrite and an acidic solution containing an acid such as acetic acid or hydrochloric acid, nitrous acid is generated and sealed in an airtight container 3 that maintains airtightness. A state in which nitrous acid is generated in the specimen extract S is maintained. As described above, in this airtight container 3, by keeping the specimen extract S in a state where the airtightness is maintained until the cap 10 is opened, for example, for a long period of 6 months or more, preferably 12 months or more. Over time, the nitrite-containing state is maintained, and the extraction ability of the group A β-hemolytic streptococcal antigen possessed by the specimen extract S can be maintained.

なお、この実施の形態においては、亜硝酸を含む検体抽出液Sとして、亜硝酸ナトリウム水溶液と、酸性溶液との2液を混合して予め生成された不安定で分解し易い亜硝酸を含む検体抽出液Sを適用した場合について述べたが、本発明はこれに限らず、亜硝酸を含む検体抽出液Sであれば、特にその生成方法については限定する必要はなく、その他種々の生成方法により生成された検体抽出液Sを適用してもよい。   In this embodiment, the sample extract S containing nitrous acid is a sample containing unstable and easily decomposed nitrous acid, which is generated in advance by mixing two solutions of a sodium nitrite aqueous solution and an acidic solution. Although the case where the extract S is applied has been described, the present invention is not limited to this, and if the sample extract S contains nitrous acid, the production method is not particularly limited, and other various production methods may be used. The generated specimen extract S may be applied.

ここで、この実施の形態の場合、容器部11は、例えば透明ガラス瓶であり、胴径Dが7〜10[mm]、全高Hが10〜40[mm]からなり、1回の検査に使用する分量の検体抽出液Sが容器部11内に封入され得るようになされている。実際上、この容器部11は、ガラス材料でなることから、側壁や底部において、内部の気体が外部へ漏れ出ることなく、かつ外部の気体が内部へ侵入することもないため、開口部13をキャップ10にて密封することで、高い気密性を維持し得、亜硝酸が含まれた状態で検体抽出液Sを長期間保持し得る。   Here, in the case of this embodiment, the container part 11 is, for example, a transparent glass bottle, and the body diameter D is 7 to 10 [mm] and the total height H is 10 to 40 [mm], which is used for one inspection. An amount of the specimen extract S can be enclosed in the container part 11. Actually, since the container portion 11 is made of a glass material, the internal gas does not leak to the outside and the external gas does not enter the inside at the side wall and the bottom portion. By sealing with the cap 10, high airtightness can be maintained, and the specimen extract S can be held for a long time in a state containing nitrous acid.

実際上、この容器部11は、検体採取用スワブ2の採取部6が挿通し得るように開口部13が形成されているとともに、容器部11内に検体抽出液Sが、例えば液高3[mm]以上で封入されており、開口部13から容器部11内に検体採取用スワブ2を挿入させた際、検体採取用スワブ2の採取部6の少なくとも先端領域が、検体抽出液Sに浸され得るようになされており、採取部6の先端領域に吸着した検体を検体抽出液Sに抽出し得るようになされている。   In practice, the container part 11 is formed with an opening 13 so that the collection part 6 of the specimen collection swab 2 can be inserted, and the specimen extract S in the container part 11 has a liquid height 3 [ mm] or more, and when the sample collection swab 2 is inserted into the container 11 through the opening 13, at least the tip region of the collection unit 6 of the sample collection swab 2 is immersed in the sample extract S. The specimen adsorbed on the tip region of the collection unit 6 can be extracted into the specimen extract S.

また、この容器部11には、開口部13の周縁側壁部に雄ねじ15が形成されており、当該雄ねじ15にキャップ10が螺着され得るようになされている。これにより、容器部11は、開口部13にパッキン18を間に挟んでキャップ10が締めつけられることで、開口部13における気密性が維持され得る。因みに、この実施の形態の場合、キャップ10は、ほぼ円盤状の天板部10aの周縁部から筒部10bが垂下しており、当該筒部10bの内周面に雌ねじ17が形成され、容器部11の雄ねじ15に対して、この雌ねじ17が螺着することで、気密性を維持した状態で容器部11の開口部13を確実に閉塞し得るようになされている。   Further, the container part 11 is formed with a male screw 15 on the peripheral side wall part of the opening part 13, and the cap 10 can be screwed onto the male screw 15. As a result, the container part 11 can maintain the airtightness in the opening part 13 by tightening the cap 10 with the packing 18 sandwiched between the opening part 13. Incidentally, in the case of this embodiment, the cap 10 has a cylindrical portion 10b hanging from the peripheral edge of the substantially disk-shaped top plate portion 10a, and an internal thread 17 is formed on the inner peripheral surface of the cylindrical portion 10b. The female screw 17 is screwed onto the male screw 15 of the part 11, so that the opening 13 of the container part 11 can be reliably closed while maintaining airtightness.

なお、キャップ10の天板部10aの裏面に設けられるパッキン18は、例えばブチルゴムや、エラストマ、EVAなどの樹脂材料を成形することにより、半硬質又は軟質な可撓性部材として形成されている。また、パッキン18は、キャップ10の天板部10aの裏面外郭形状に合わせてほぼ円盤状に形成されており、キャップ10の天板部10aと、容器部11の開口部13とに当接し、開口部13を確実に密封し得るようになされている。   The packing 18 provided on the back surface of the top plate portion 10a of the cap 10 is formed as a semi-rigid or soft flexible member by molding a resin material such as butyl rubber, elastomer, EVA or the like. In addition, the packing 18 is formed in a substantially disc shape in accordance with the outer shape of the back surface of the top plate portion 10a of the cap 10, and contacts the top plate portion 10a of the cap 10 and the opening portion 13 of the container portion 11, The opening 13 can be surely sealed.

実際上、パッキン18は、気密容器3内の亜硝酸と反応せず、かつガス透過性が低く、気密容器3内で生成されるガスが非透過となる樹脂部材で形成されることが望ましく、例えば上述したブチルゴム等の他、シリコンゴムや、フッ素ゴム、多硫化ゴム、ニトリルゴム、アクリルゴム、ウレタンゴム等その他種々の樹脂材料で形成してもよい。また、パッキン18は、気密容器3内の気密性を長期間維持する必要があるため、保存期間中、経時劣化し難い樹脂部材により形成されることが望ましい。   In practice, the packing 18 is preferably formed of a resin member that does not react with nitrous acid in the hermetic container 3, has low gas permeability, and does not allow gas generated in the hermetic container 3 to pass through. For example, in addition to the above-described butyl rubber, etc., other various resin materials such as silicon rubber, fluorine rubber, polysulfide rubber, nitrile rubber, acrylic rubber, and urethane rubber may be used. Further, since the packing 18 needs to maintain the hermeticity in the hermetic container 3 for a long period of time, it is desirable that the packing 18 be formed of a resin member that hardly deteriorates with time during the storage period.

ここで、パッキン18は、例えば亜硝酸から生成される一酸化窒素等のガスを非透過とし、気密容器3内の気密性を維持し得る樹脂部材で形成されることが望ましく、パッキン18を形成する樹脂部材について、一酸化窒素等よりも分子が小さい窒素ガスを基準に規定した場合、温度25℃において窒素ガス透過係数が4.8[ml・cm/cm2・sec・cmHg]以下の樹脂部材により形成されることが望ましく、より好ましくはガス透過性が低いブチルゴムの窒素ガス透過係数以下、すなわち温度25℃において窒素ガス透過係数0.247[ml・cm/cm2・sec・cmHg]以下であることが望ましい。Here, the packing 18 is preferably formed of a resin member that does not permeate gas such as nitric oxide generated from nitrous acid and can maintain the airtightness in the airtight container 3, and the packing 18 is formed. If the resin member is specified based on nitrogen gas whose molecule is smaller than that of nitrogen monoxide, etc., the resin member having a nitrogen gas permeability coefficient of 4.8 [ml · cm / cm 2 · sec · cmHg] or less at a temperature of 25 ° C. Desirably formed, more preferably less than the nitrogen gas permeability coefficient of butyl rubber having low gas permeability, that is, a nitrogen gas permeability coefficient of 0.247 [ml · cm / cm 2 · sec · cmHg] at a temperature of 25 ° C. desirable.

なお、窒素ガス透過係数は、樹脂部材で形成した試験片について、1[cm]の厚さで、試験片の一面側と他面側との圧力差1気圧(760[mmHg])1[cm2]当り、1秒間に通過する25[℃]における窒素ガスの透過量を示す。因みに、上述したブチルゴムの窒素ガス透過係数は、「日本ゴム協会誌,Vol.53(1980)No.12.公開日:2008年04月16日,「ゴム技術者のための入門講座[III]わかりやすいゴムの物性(12)」, 剣菱 浩(https://www.jstage.jst.go.jp/article/gomu1944/53/12/53_12_719/_pdf)」に記載された窒素ガス透過係数を目安としている。The nitrogen gas permeability coefficient is 1 [cm] for the test piece formed of a resin member, and the pressure difference between one side of the test piece and the other side is 1 atm (760 [mmHg]) 1 [cm 2 ] shows the permeation amount of nitrogen gas at 25 [° C.] per second. By the way, the nitrogen gas permeability coefficient of butyl rubber mentioned above is "Japan Rubber Association Journal, Vol. 53 (1980) No.12. Release Date: April 16, 2008," Introductory Course for Rubber Engineers [III] Easy-to-understand physical properties of rubber (12) ”, Hiroshi Kenbishi (https://www.jstage.jst.go.jp/article/gomu1944/53/12/53_12_719/_pdf) It is said.

このように気密容器3は、1回の検査に使用する分量の検体抽出液Sが、気密性の高い容器部11内に入れられ、かつ開口部13にパッキン18を間に挟んでキャップ10が締めつけられることで、開口部13における気密性が維持され、検体抽出液Sが完全に外気と隔離された状態で封入され、キャップ10が取り外されるまでの間、亜硝酸を含んだ状態で検体抽出液Sを保存し得るようになされている。   As described above, the airtight container 3 is filled with the sample extract S of an amount to be used for one test in the highly airtight container part 11, and the cap 10 is sandwiched between the opening 18 and the packing 18 therebetween. By tightening, the airtightness at the opening 13 is maintained, the specimen extract S is sealed in a state completely isolated from the outside air, and the specimen is extracted in a state containing nitrous acid until the cap 10 is removed. The liquid S can be stored.

次に、この糖鎖抗原抽出キット1を用いて、A群β溶血連鎖球菌抗原の存在の有無を検査する際の一連の作業について以下説明する。この場合、被検者の炎症部分である例えば咽頭を、検体採取用スワブ2の採取部6によりぬぐって、採取部6に検体を吸着させる。この際、検体採取用スワブ2の採取部6には、検体が内部に染み込むことなく、表面にある立毛表層部7に検体が毛細管現象や表面張力により吸着する。そして、使用者は、容器部11からキャップ10を外し、気密性が維持されていた気密容器3を開封し、図3に示すように、開口部13から容器部11内に検体採取用スワブ2の採取部6を挿入し、容器部11内の検体抽出液Sに採取部6を所定時間浸す。   Next, a series of operations for examining the presence or absence of the group A β-hemolytic streptococcal antigen using this sugar chain antigen extraction kit 1 will be described below. In this case, for example, the pharynx, which is an inflamed part of the subject, is wiped by the collection unit 6 of the sample collection swab 2, and the sample is adsorbed to the collection unit 6. At this time, the sample is adsorbed to the napped surface layer portion 7 on the surface by the capillary phenomenon or the surface tension without the sample soaking into the collection unit 6 of the sample collection swab 2. Then, the user removes the cap 10 from the container part 11 and opens the airtight container 3 whose airtightness has been maintained. As shown in FIG. 3, the sample collection swab 2 enters the container part 11 from the opening part 13. The sampling unit 6 is inserted, and the sampling unit 6 is immersed in the sample extract S in the container unit 11 for a predetermined time.

その後、検体採取用スワブ2は、容器部11から取り出されるが、その際、採取部6を従来のように、しごくことなく、立毛表層部7を容器部11の内壁に対し単に押し当てるだけで、毛細管現象や表面張力によって立毛表層部7に吸着していた検体や検体抽出液が内壁に沿って流下し、余分な検体や検体抽出液を立毛表層部7から取り除くことができ、検体抽出液S内に検体が含まれた試液を容器部11内に、より多く残すことができる。   Thereafter, the sample-collecting swab 2 is taken out from the container part 11, and at that time, the napping surface layer part 7 is simply pressed against the inner wall of the container part 11 without squeezing the collecting part 6 as in the prior art. The specimen or specimen extract adsorbed on the napped surface layer part 7 due to capillary action or surface tension flows down along the inner wall, and the excess specimen or specimen extract can be removed from the napped surface layer part 7. More reagent solution containing the sample in S can be left in the container part 11.

ここで、容器部11内の検体抽出液Sは、気密容器3のキャップ10の開封時、亜硝酸が含まれており、検体中にA群β溶血連鎖球菌抗原が含まれているとき、当該亜硝酸の働きによって、検体中の多糖抗原たるA群β溶血連鎖球菌抗原を菌体から遊離させ、検体からA群β溶血連鎖球菌抗原を抽出し得るようになされている。   Here, the specimen extract S in the container part 11 contains nitrous acid when the cap 10 of the airtight container 3 is opened, and when the specimen contains a group A β-hemolytic streptococcal antigen, By the action of nitrous acid, a group A β-hemolytic streptococcal antigen, which is a polysaccharide antigen in the sample, is released from the cells, and the group A β-hemolytic streptococcal antigen can be extracted from the sample.

最後に、容器部11内の試液に、テストストリップの判定部を浸し、所定時間経過後、判定部における抗原抗体反応によるライン出現の有無を目視にて確認し、当該ライン出現の有無を基に、試液内にA群β溶血連鎖球菌抗原が存在するか否かを判定し得る。   Finally, the test strip determination unit is immersed in the test solution in the container unit 11, and after a predetermined time has passed, the presence or absence of a line due to an antigen-antibody reaction in the determination unit is visually confirmed. Whether the group A β-hemolytic streptococcal antigen is present in the test solution can be determined.

(2)作用及び効果
以上の構成において、この糖鎖抗原抽出キット1では、亜硝酸を含む検体抽出液Sを、気密性を維持した気密容器3に封入するようにしたことにより、検体抽出液Sを気密容器3に封入したときから、A群β溶血連鎖球菌抗原の有無の検査に検体抽出液Sを使用するときまでの長期間、不安定な亜硝酸を検体抽出液Sに含ませた状態のまま、当該検体抽出液Sを保存し続けることができる。
(2) Actions and effects In the above-described configuration, in this sugar chain antigen extraction kit 1, the sample extract S containing nitrous acid is sealed in an airtight container 3 that maintains airtightness. From the time when S was sealed in the airtight container 3 to the time when the sample extract S was used for the presence or absence of group A β-hemolytic streptococcal antigen, unstable nitrous acid was included in the sample extract S. The specimen extract S can be continuously stored in the state.

また、この糖鎖抗原抽出キット1では、予め最適な混合割合で調製して生成した亜硝酸を含む検体抽出液Sを、気密容器3に封入させておくことができるので、従来、医療現場で行われていた亜硝酸ナトリウム水溶液と酸性溶液との2液を混合して亜硝酸を含む検体抽出液をその都度生成する用時調製を省くことができ、その分、使用者の負担を軽減させることができる。   Further, in this sugar chain antigen extraction kit 1, the specimen extract S containing nitrous acid prepared and prepared in advance at an optimal mixing ratio can be sealed in the airtight container 3, so that it has been conventionally used in the medical field. Mixing two liquids of sodium nitrite aqueous solution and acidic solution that have been performed to produce a sample extract containing nitrous acid each time can be omitted, thereby reducing the burden on the user. be able to.

また、この糖鎖抗原抽出キット1では、採取部6の内部にまで検体が浸透することなく、検体が毛細管現象や表面張力により立毛表層部7に吸着する検体採取用スワブ2を用いるようにしたことから、容器部11内の検体抽出液Sに採取部6を浸すだけで、立毛表層部7に吸着した検体を検体抽出液Sに放出でき、また、採取部6を容器部11から取り出す際、立毛表層部7を容器部11の内壁(所定部位)に押し付けるだけで、立毛表層部7に吸着した検体や検体抽出液が内壁に沿って流下することから、より多くの検体抽出液Sを容器部11内に回収できる。   In addition, the sugar chain antigen extraction kit 1 uses the sample collection swab 2 in which the sample does not penetrate into the collection unit 6 and the sample is adsorbed to the raised surface layer portion 7 by capillary action or surface tension. Therefore, the sample adsorbed on the napped surface layer portion 7 can be released to the sample extract S simply by immersing the collection portion 6 in the sample extract S in the container portion 11, and when removing the collection portion 6 from the container portion 11 Because the specimen and specimen extract adsorbed on the raised surface layer portion 7 flow down along the inner wall simply by pressing the raised surface layer section 7 against the inner wall (predetermined part) of the container section 11, more specimen extract S It can be collected in the container part 11.

ところで、図10Aに示したように、従来、綿棒105により被検者から採取した検体を検体抽出液に抽出する際には、綿棒105の先端綿球部105aに染み込んだ検体を絞り出すために、指で先端綿球部105aを強く摘んで擦るしごく作業が必ず必要であったことから、このしごき作業が確実に行えるように、使用者の把持力により簡単に潰れる柔軟性のある軟質材料にて製造された抽出用チューブ100を使用せざるをえなかった。   By the way, as shown in FIG. 10A, conventionally, when extracting a sample collected from a subject with a cotton swab 105 into a sample extract, in order to squeeze the sample soaked into the tip cotton ball portion 105a of the cotton swab 105, Since it was necessary to squeeze and rub the tip cotton ball 105a with your finger strongly, a flexible soft material that can be easily crushed by the gripping force of the user to ensure that this squeezing operation can be performed. The manufactured extraction tube 100 had to be used.

このように、従来の抽出用チューブ100は、しごき作業を第一に考慮して、柔軟性のある軟質材料にて製造されていることから、検体抽出液が漏れ出ることはないものの、気密性に乏しく、仮に開口部にキャップを設けて開口部を閉塞しても、時間経過とともに、不安定な亜硝酸が気化して、生成時から約24時間後には、検体抽出液が持っていたA群β溶血連鎖球菌抗原の抽出能力が発揮され得ない状態となってしまう。   As described above, the conventional extraction tube 100 is manufactured from a flexible soft material in consideration of the ironing operation. Even if a cap is provided in the opening to close the opening, unstable nitrous acid vaporizes over time, and the sample extract had A after about 24 hours from the time of generation. The ability to extract group β hemolytic streptococcal antigens cannot be achieved.

これに対してこの糖鎖抗原抽出キット1では、従来必ず行っていたしごき作業ができない硬質材料でなる気密容器3に、検体抽出液Sを封入して気密性を維持することで、検体抽出液Sに含まれる亜硝酸の気化を防止し、検体抽出液Sの持つA群β溶血連鎖球菌抗原の抽出能力を保持した状態で長期保存を可能にした。   On the other hand, in this sugar chain antigen extraction kit 1, the sample extract S is sealed by enclosing the sample extract S in a hermetic container 3 made of a hard material that has always been performed and cannot be rubbed. It prevents vaporization of nitrous acid contained in S and enables long-term storage while maintaining the extraction ability of the group A β-hemolytic streptococcal antigen possessed by the sample extract S.

そして、この糖鎖抗原抽出キット1では、容器部11の内壁に立毛表層部7を単に押し当てることで、立毛表層部7に吸着した検体や検体抽出液を取り除くことができる検体採取用スワブ2を用いるようにしたことで、使用者の把持力により非変形なガラス材料(硬質ガラス)等の硬質材料でなり、しごき作業が行えない容器部11を用いても、従来のしごき作業を行ったときと同じように検体を検体抽出液Sに抽出させることができ、また、試液が検体採取用スワブ2に吸われることなく容器部11内により多くの試液を残させ、従来と同様に、A群β溶血連鎖球菌抗原の存在の有無を検査できる。   In this sugar chain antigen extraction kit 1, the sample collection swab 2 can remove the sample adsorbed on the napped surface layer portion 7 and the sample extract by simply pressing the napped surface layer portion 7 against the inner wall of the container portion 11. As a result, the conventional ironing operation was performed even when using the container part 11 which is made of a hard material such as a non-deformable glass material (hard glass) and cannot perform the ironing operation due to the gripping force of the user. The sample can be extracted into the sample extract S in the same manner as in the above, and more sample solution is left in the container part 11 without the sample solution being sucked into the sample collection swab 2. The presence or absence of group β hemolytic streptococcal antigen can be examined.

また、この実施の形態の場合、容器部11は、透明ガラス瓶のような硬質材料により成形されていることから、使用者の把持力だけでなく、仮に運搬中に何らかの原因によって外部から衝撃が与えられたとしても、容器部11自体が変形し難く、容器部11の気密性を維持した状態を保つことができ、キャップ10の開封時まで亜硝酸を検体抽出液Sに含ませ続けることができる。   In the case of this embodiment, since the container portion 11 is formed of a hard material such as a transparent glass bottle, not only the gripping force of the user but also an impact from the outside due to some cause during transportation is given. Even if the container part 11 itself is deformed, the container part 11 itself is not easily deformed, and the container part 11 can be kept airtight, and nitrous acid can be continuously contained in the specimen extract S until the cap 10 is opened. .

さらに、この実施の形態の場合、容器部11は、透明ガラス瓶により成形され、容器部11内が目視確認可能であることから、検体採取用スワブ2の採取部6を検体抽出液Sに浸されている状況や、試液の液量等を目視確認しながら作業を行うことができる。   Further, in the case of this embodiment, the container part 11 is formed of a transparent glass bottle, and the inside of the container part 11 can be visually confirmed. Therefore, the collection part 6 of the sample collection swab 2 is immersed in the sample extraction liquid S. The work can be performed while visually confirming the situation and the amount of the test solution.

以上の構成によれば、この糖鎖抗原抽出キット1では、気密性を維持した気密容器3に、予め調製した亜硝酸を含む検体抽出液Sを封入するようにしたことで、従来不可能であった亜硝酸を含ませた状態での検体抽出液Sの長期保存を可能とし、その結果、医療現場での用時調製を不要にできるとともに、誤った調製をも防止でき、さらに気密容器3に1液だけが封入した簡易な構成となる分、製造コストも低減できる。   According to the above configuration, this sugar chain antigen extraction kit 1 is impossible in the past because the specimen extract S containing nitrous acid prepared in advance is sealed in the airtight container 3 that maintains airtightness. This makes it possible to store the specimen extract S in a state containing the nitrous acid for a long period of time, which eliminates the need for pre-use preparation at the medical site and prevents incorrect preparation. The manufacturing cost can be reduced by the simple structure in which only one solution is enclosed.

(3)検証試験
(3-1)検体抽出液の保存性について
次に、市販のA群β溶血連鎖球菌抗原キットを7種類用意し、これら7種類のA群β溶血連鎖球菌抗原キットにて用いる各検体抽出液の抗原抽出能力がどの程度持続するかについて調べた。ここでは、A群β溶血連鎖球菌抗原キットとして、クリアビューストレップ(株式会社三和化学研究所製)、BinaxNow(アリーア メディカル株式会社製)、エルナス(株式会社テイエフビー製)、イムノカード(株式会社テイエフビー製)、スタットチェックストレップA(株式会社ニチレイバイオサイエンス製)、ラピッドテスタ(積水メディカル株式会社製)、クイックビュー(DSファーマバイオメディカル株式会社製)の7種類を用いた。
(3) Verification test (3-1) Preservability of specimen extract Next, seven types of commercially available group A β-hemolytic streptococcal antigen kits were prepared, and these seven types of group A β-hemolytic streptococcal antigen kits were used. It was examined how long the antigen extraction ability of each specimen extract to be used lasted. Here, as a group A β-hemolytic streptococcal antigen kit, Clear View Strep (manufactured by Sanwa Chemical Laboratories Co., Ltd.), BinxNow (manufactured by Allia Medical Co., Ltd.), Elnas (manufactured by TAF Co., Ltd.), Immunocard (Co., Ltd.) Seven types, TF Check), Stat Check Strep A (manufactured by Nichirei Bioscience), Rapid Tester (manufactured by Sekisui Medical Co., Ltd.), and Quick View (manufactured by DS Pharma Biomedical Co., Ltd.) were used.

これら7種類のA群β溶血連鎖球菌抗原キットは、いずれもイムノクロマトグラフィーを原理としており、亜硝酸ナトリウムを含む溶液と、酢酸等の酸性溶液とを混合して検体抽出液を用時調製し、被検者の咽頭を綿棒で擦過して採取した検体を検体抽出液に入れ、例えば1分間抽出することで多糖抗原を菌体より遊離して試液を調製するものである。   These seven types of group A β-hemolytic streptococcal antigen kits are all based on immunochromatography, and a sample extract is prepared at the time of use by mixing a solution containing sodium nitrite and an acidic solution such as acetic acid. A sample collected by rubbing the pharynx of a subject with a cotton swab is placed in a sample extract, and extracted, for example, for 1 minute to release polysaccharide antigens from the cells and prepare a test solution.

この場合、これら7種類のA群β溶血連鎖球菌抗原キットについて、能書の用量用法に従って各容器に2種の薬液を混合して亜硝酸を含んだ検体抽出液をそれぞれ生成し、直ちに5×107個/mlのA群β溶血連鎖球菌(溶連菌:StreptococcusA,Micro Detect,Inc.)を10[μL]、各容器に添加し、1〜2分間放置後、各A群β溶血連鎖球菌抗原キットの用量用法に従い、イムノクロマト反応を開始した。そして、各A群β溶血連鎖球菌抗原キットの能書に指定された反応時間終了後に、イムノクロマトリーダーC10066(浜松ホトニクス株式会社製)にてライン強度を測定したところ、図4に示すような結果(図4中「0」と表記)が得られた。In this case, for these seven types of group A β-hemolytic streptococcal antigen kits, each container is mixed with two chemicals according to the dosage method of Nohsho to produce each sample extract containing nitrous acid, and immediately 5 × 10 7 / ml group A β-hemolytic streptococci (Streptococcus A, Micro Detect, Inc.) 10 [μL], added to each container, left for 1-2 minutes, then each group A β-hemolytic streptococcal antigen The immunochromatographic reaction was initiated according to the kit dosage regimen. And after completion | finish of reaction time designated by the ability book of each A group (beta) hemolytic streptococcus antigen kit, when the line intensity | strength was measured with immunochromatography reader C10066 (made by Hamamatsu Photonics Co., Ltd.), the result as shown in FIG. 4 ( In FIG. 4, "0" is obtained).

また、これとは別に、これら7種類のA群β溶血連鎖球菌抗原キットについて、能書の用量用法に従って各容器に2種の薬液を混合して亜硝酸を含んだ検体抽出液をそれぞれ生成し、22時間(一日)放置後、5×107個/mlのA群β溶血連鎖球菌を10[μL]、各容器に添加し、1〜2分間放置後、各A群β溶血連鎖球菌抗原キットの用量用法に従い、イムノクロマト反応を開始した。そして、各A群β溶血連鎖球菌抗原キットの能書に指定された反応時間終了後に、イムノクロマトリーダーC10066(浜松フォトニクス)にてライン強度を測定したところ、図4に示すような結果(図4中「22」と表記)が得られた。Separately, for these seven types of group A β-hemolytic streptococcal antigen kits, two chemical solutions are mixed in each container according to the dosage method of the Noboru and each sample extract containing nitrous acid is generated. After leaving for 22 hours (one day), add 10 [μL] of group A β-hemolytic streptococci at 5 × 10 7 cells / ml to each container and leave it for 1 to 2 minutes. The immunochromatographic reaction was started according to the dosage regimen of the antigen kit. Then, after completion of the reaction time specified in the booklet of each group A β-hemolytic streptococcal antigen kit, the line intensity was measured with an immunochromatographic reader C10066 (Hamamatsu Photonics), and the results shown in FIG. 4 (in FIG. 4) "22") was obtained.

図4の結果から、全てのA群β溶血連鎖球菌抗原キットで、検体抽出液によるA群β溶血連鎖球菌抗原を抽出する抽出能力が時間経過とともに失われてしまっていることが確認できた。このために、従来のA群β溶血連鎖球菌抗原キットでは、亜硝酸ナトリウムと酸とを使用直前に混合しなくてはいけないことが分かる。   From the results of FIG. 4, it was confirmed that the extraction ability to extract the group A β-hemolytic streptococcal antigen by the sample extract was lost over time in all the group A β-hemolytic streptococcal antigen kits. For this reason, it can be seen that in the conventional group A β-hemolytic streptococcal antigen kit, sodium nitrite and acid must be mixed immediately before use.

次に、下記の表1に示す7種類の容器を用いて、亜硝酸ナトリウムと酢酸とを添加して亜硝酸を含んだ検体抽出液を生成し、これら容器毎にそれぞれ検体抽出液の保存実験を行った。   Next, using the seven types of containers shown in Table 1 below, sodium nitrite and acetic acid are added to produce a sample extract containing nitrous acid, and the sample extract is stored in each of these containers. Went.

Figure 0006182526
Figure 0006182526

具体的に、この実験では、使用容器として、LDポリエチレンチューブ(株式会社シン・コーポレイション製)、エッペンセーフロックマイクロテストチューブ(エッペンドルフ株式会社製)、TP311(PET(ポリエチレンテレフタレート(PolyEthylene Terephthalate))チューブ、アズワン株式会社製)、アシストチューブ(株式会社アシスト製)、ガラス瓶(日電理化硝子株式会社製、パッキンS-08用(ブチルゴム)、キャップ S-08用(黒)(フェノール樹脂))、ガラスバイアル1(オートサンプラー用バイアル+AGキャップ、パッキン(テフロン(登録商標)/ラバーの2層):アズワン製)、ガラスバイアル2(オートサンプラー用バイアル+AGキャップ、パッキン(テフロン/シリコンの2層):アズワン製)を用いた。   Specifically, in this experiment, LD polyethylene tubes (manufactured by Shin Corporation), Eppen Safe Lock micro test tubes (manufactured by Eppendorf), TP311 (PET (PolyEthylene Terephthalate)) tubes, ASONE Co., Ltd.), assist tube (Assist Co., Ltd.), glass bottle (manufactured by Nidec Rika Glass Co., Ltd., packing S-08 (butyl rubber), cap S-08 (black) (phenolic resin)), glass vial 1 (Autosampler vial + AG cap, packing (2 layers of Teflon (registered trademark) / rubber): manufactured by ASONE), Glass vial 2 (autosampler vial + AG cap, packing (2 layers of Teflon / silicon): ASONE) Made).

また、この実験では、ニトロセルロースメンブラン(MilliPore)に、抗ストレップAウサギポリクローナル抗体を1[μL/cm]の割合でライン状に塗布をしたテストメンプランと、抗ストレップAウサギポリクローナル抗体を金コロイドと結合させた標識金コロイドを、コンジュゲートパットに染み込ませて乾燥させた標識物コンジュゲートパットとを組み合わせて、イムノクロマト測定用ストリップを作製した。   In this experiment, a test membrane plan in which an anti-strept A rabbit polyclonal antibody was applied in a line form at a rate of 1 [μL / cm] to a nitrocellulose membrane (MilliPore), and an anti-strept A rabbit polyclonal antibody was colloidal in gold colloid. An immunochromatographic measurement strip was prepared by combining the labeled gold colloid bound to the conjugate pad with the conjugate conjugate pad soaked in the conjugate pad and dried.

そして、各使用容器にそれぞれ検体抽出液を入れ、キャップをして使用容器内を外気から隔離した状態にし、それぞれ検体抽出液がどの程度の期間まで抗原の抽出能力を有しているか否かを、イムノクロマト測定用ストリップを用いた抗原抗体反応を基に評価を行ったところ、上記の表1のような結果が得らえた。   Then, put each sample extract into each use container, cap it and keep the inside of the use container isolated from the outside air, and to what extent each sample extract has the ability to extract antigen As a result of evaluation based on the antigen-antibody reaction using an immunochromatographic measurement strip, the results shown in Table 1 above were obtained.

なお、表1では、テストラインを目視で検出し陽性判定したときを「+」で表し、テストラインの検出がぎりぎり見える程度の弱いライン強度の陽性判定を「 + 」で表し、テストラインが検出できない陰性判定を「-」で表している。In Table 1, represents when it is determined by detecting the test line visually positive "+" represents a positive determination of line of weakness strength enough to detect the test line appears barely at "+", the test line detection Negative judgments that cannot be made are indicated by “-”.

表1から、各使用容器によって、検体抽出液の抽出能力の有効な保安性の期間がそれぞれ異なることが分かった。具体的に、表1から、ポリエチレン、PET、ポリスチレンを主たる材料とした市販の使用容器は、検体抽出液の抽出能力が2か月と持たず、その反応性を維持できないのに対して、ガラスを素材とした使用容器を用いることで、検体抽出液の抽出能力が12か月以上に亘って長く維持されることが確認できた。   From Table 1, it was found that the effective security period of the extraction ability of the specimen extract was different depending on each container used. Specifically, from Table 1, commercially available containers made mainly of polyethylene, PET, and polystyrene do not have the ability to extract specimen extracts for 2 months, and cannot maintain their reactivity, It was confirmed that the extraction capacity of the sample extract was maintained for a long period of 12 months or longer by using the container made of the material.

因みに、上記実験から、検体抽出液の抽出能力を維持するためには、ガラス材料を用いた容器部11が好ましいことが確認できたが、本発明はこれに限らず、例えばポリエチレンや、PET、ポリスチレンのような合成樹脂材料であっても、容器部の側壁及び底部を肉厚とし気密性を向上させたり、合成樹脂材を高密度で成形して気密性を向上させたり、或いは気密性シートを容器部の内壁等に貼着して容器部内の気密性を向上させるようにしてよく、また気密性の高い金属材料で容器部を形成するようにしてもよい。   Incidentally, from the above experiments, it was confirmed that the container 11 using a glass material is preferable in order to maintain the extraction ability of the specimen extract, but the present invention is not limited to this, for example, polyethylene, PET, Even if it is a synthetic resin material such as polystyrene, the side wall and bottom of the container part are thickened to improve the airtightness, the synthetic resin material is molded at a high density to improve the airtightness, or the airtight sheet May be adhered to the inner wall or the like of the container part to improve the airtightness in the container part, or the container part may be formed of a metal material having high airtightness.

すなわち、気密容器3としては、キャップ10の開封まで容器部11内の気密性を維持して、検体抽出液Sが持つ検出対象物の抽出能力を長期間に亘って保持できれば、この他種々の材料を用いて容器部を成形したり、種々の構造でなる容器部を適用してもよい。そして、これら種々の気密容器としては、気密性を維持した状態で検体抽出液Sを保存し続けることで、検体抽出液Sが持つ検出対象物の抽出能力を、少なくとも6か月、好ましくは12か月以上持続させることができることが好ましい。   In other words, as long as the hermetic container 3 can maintain the hermeticity in the container part 11 until the cap 10 is opened and can maintain the extraction ability of the detection target of the specimen extract S over a long period of time, various other types You may shape | mold a container part using a material, and may apply the container part which consists of various structures. And, as these various airtight containers, by continuing to store the sample extract S while maintaining airtightness, the extraction ability of the detection target possessed by the sample extract S is at least 6 months, preferably 12 It is preferable that it can last for more than a month.

また、ブチルゴムのパッキンを用いた表1のガラス瓶(日電理化硝子株式会社製、パッキンS-08用(ブチルゴム)、キャップ S-08用(黒)(フェノール樹脂))に検体抽出液Sを封入して気密状態を維持したまま6か月間保存し、6か月後にキャップを開封して、容器部内の検体抽出液Sに上述したイムノクロマト測定用ストリップを漬けた後、イムノクロマトリーダーC10066-10(浜松ホトニクス株式会社製)によりテストラインのライン強度について数値を調べた。   In addition, the sample extract S is sealed in the glass bottle of Table 1 using packing of butyl rubber (manufactured by Nidec Rika Glass Co., Ltd., for packing S-08 (butyl rubber), for cap S-08 (black) (phenolic resin)). After 6 months, the cap is opened and the above-mentioned immunochromatographic strip is immersed in the sample extract S in the container, and then the immunochromatographic reader C10066-10 (Hamamatsu Photonics) is stored. Numerical value was examined for the line strength of the test line.

また、テフロン/ラバー(天然ゴム)の2層構造のパッキンを用いた表1に示すガラスバイアル1と、テフロン/シリコンの2層構造のパッキンを用いた表1に示すガラスバイアル2についても、上述と同様に、内部に検体抽出液Sを封入して気密状態を維持したまま6か月間保存した後、キャップを開封して、容器部内の検体抽出液Sに上述したイムノクロマト測定用ストリップを漬けた後、イムノクロマトリーダーC10066-10(浜松ホトニクス株式会社製)によりテストラインのライン強度について数値を調べた。   The glass vial 1 shown in Table 1 using a two-layer packing of Teflon / rubber (natural rubber) and the glass vial 2 shown in Table 1 using a two-layer packing of Teflon / silicon are also described above. In the same manner as above, the sample extract S was sealed inside and stored for 6 months while maintaining an airtight state, then the cap was opened, and the above-described immunochromatographic measurement strip was immersed in the sample extract S in the container part. Thereafter, numerical values were examined for the line strength of the test line using an immunochromatographic reader C10066-10 (manufactured by Hamamatsu Photonics Co., Ltd.).

その結果、ブチルゴムのパッキンを用いたガラス瓶では、6か月後のライン強度保持率が約78%であり、一方、テフロン/ラバーの2層構造のパッキンを用いたガラスバイアル1では、6か月後のライン強度保持率が約15%であった。また、テフロン/シリコンの2層構造のパッキンを用いたガラスバイアル2では、6か月後のライン強度保持率が約9%であった。   As a result, in the glass bottle using butyl rubber packing, the line strength retention after 6 months is about 78%, while in the glass vial 1 using Teflon / rubber two-layer packing, 6 months. Later line strength retention was about 15%. Further, in the glass vial 2 using the Teflon / silicon two-layer packing, the line strength retention after 6 months was about 9%.

このことから、ブチルゴムのパッキンを用いたガラス瓶では、他のガラスバイアル1やガラスバイアル2よりも、内部の気密性が一段と維持され、検体抽出液Sが持つ検出対象物の抽出能力を高い状態のまま6か月持続させることができ、密封から6か月後でも臨床試験に使用可能なほど抽出能力を維持できることが確認できた。このことは、ガラス瓶と、ガラスバイアル1,2とではキャップ構造の違いはあるものの、気密容器3内の気密性を維持できるか否かについては、主として容器部の開口部を覆うパッキンの材質による違いも大きく、気密容器3内の気密性を維持するためにはブチルゴムのパッキンを用いることが望ましいことが確認できた。よって、検体抽出液Sが持つ検出対象物の抽出能力を、長期間に亘って高い状態のまま維持するためには、ブチルゴムの窒素ガス透過係数(25[℃]で0.247[ml・cm/cm2・sec・cmHg])以下の樹脂部材からなるパッキンを用いることが最も望ましいことが確認できた。Therefore, in the glass bottle using the butyl rubber packing, the internal airtightness is further maintained as compared with the other glass vials 1 and 2, and the extraction ability of the detection target of the specimen extract S is higher. It was confirmed that the extractability could be maintained so that it could be used for clinical trials even 6 months after sealing. Although this has a difference in cap structure between the glass bottle and the glass vials 1 and 2, whether or not the airtightness in the airtight container 3 can be maintained depends mainly on the material of the packing covering the opening of the container part. It was confirmed that it was desirable to use butyl rubber packing in order to maintain the airtightness in the airtight container 3. Therefore, in order to maintain the extraction ability of the sample extraction liquid S that remains high for a long period of time, the nitrogen gas permeability coefficient of butyl rubber (25 [° C] is 0.247 [ml · cm / cm 2 · sec · cmHg]) It was confirmed that it was most desirable to use a packing made of the following resin member.

(3-2)検体採取用スワブについて
次に、4種類の検体採取用スワブを用意し、各検体採取用スワブの検体の回収率について検証を行った。具体的にこの実験では、上述した実施の形態にて説明した立毛表層部7を備える検体採取用スワブ2であるフログドスワブと、表面に多孔質を有したスポンジからなる採取部を備えたスポンジスワブと、先端部がループ状に折り曲げられO状に形成されたループと、一般的に綿棒と呼ばれる通常のレイヨンスワブの4種類を用意した。
(3-2) Sample collection swabs Next, four types of sample collection swabs were prepared, and the sample recovery rate of each sample collection swab was verified. Specifically, in this experiment, a flogged swab, which is a sample collecting swab 2 provided with a raised surface layer portion 7 described in the above-described embodiment, and a sponge swab provided with a collecting portion made of a sponge having a porous surface, Four types were prepared: a loop whose tip was bent into a loop shape and formed into an O shape, and a normal rayon swab generally called a cotton swab.

ここで、コントロールは、蒸留水を0.7[ml]入れたガラスバイアル(外径14[mm]、全高30[mm])に、100[mg/ml]のBSA水溶液を10[μL]加えて、その吸光度(OD280[nm])を3回測定し、BSAの吸光係数を0.584(0.584=1mgBSA/ml)として、その数字から濃度を求め、ガラスバイアル当たりの量に換算し、それを100[%]回収とした。   Here, 10 [μL] of 100 [mg / ml] BSA aqueous solution was added to a glass vial (outer diameter 14 [mm], total height 30 [mm]) containing 0.7 [ml] distilled water, The absorbance (OD280 [nm]) was measured three times, the BSA extinction coefficient was set to 0.584 (0.584 = 1 mgBSA / ml), the concentration was calculated from that number, converted into the amount per glass vial, and 100 [% It was a recovery.

そして、これら4種類の各検体採取用スワブに、それぞれ100[mg/ml]のBSA水溶液を10[μL]吸わせて、0.7[ml]の蒸留水を入れたガラスバイアルの内壁に、BSA水溶液を吸わせた先端部を10回押し当てるように回してBSAを抽出回収し、吸光度を測定した。なお、Blankとして検体採取用スワブのみで抽出操作を行い、得られた数字を各検体採取用スワブからのBSA回収操作で得られた値から引き補正した。得られた吸光度から、濃度を換算し、回収量を算出し回収率を求めたところ、下記の表2のような結果が得られた。   Then, 10 [μL] of 100 [mg / ml] BSA aqueous solution was sucked into each of these 4 types of sample collection swabs, and the BSA aqueous solution was placed on the inner wall of a glass vial containing 0.7 [ml] distilled water. BSA was extracted and recovered by rotating the tip so that the tip was sucked 10 times, and the absorbance was measured. In addition, extraction operation was performed only with the sample collection swab as Blank, and the obtained number was subtracted and corrected from the value obtained by the BSA recovery operation from each sample collection swab. When the concentration was converted from the obtained absorbance, the recovery amount was calculated and the recovery rate was determined, the results shown in Table 2 below were obtained.

Figure 0006182526
Figure 0006182526

表2から、従来のA群β溶血連鎖球菌抗原キットに用いられているレイヨンスワブ(綿棒)は、先端部分を単に壁に押し当てるだけでは回収率が7.2[%]と極めて低くなってしまい、先端部分をしごき、回収率を上げる必要があることが分かる。ここで、本発明による糖鎖抗原抽出キット1を構成する気密容器3は、例えばガラス材料等の硬質材料でなることから、使用者の把持力により変形させることが困難であり、容器部11自体を変形させて容器部11内のレイヨンスワブの先端部分をしごくことができない。従って、回収率を高めるために先端部をしごく作業が必要となるレイヨンスワブは、上述した実施の形態による糖鎖抗原抽出キット1に用いることは好ましくない。   From Table 2, the rayon swab (cotton swab) used in the conventional group A β-hemolytic streptococcal antigen kit has an extremely low recovery rate of 7.2 [%] by simply pressing the tip portion against the wall. It can be seen that it is necessary to squeeze the tip to increase the recovery rate. Here, since the airtight container 3 constituting the sugar chain antigen extraction kit 1 according to the present invention is made of a hard material such as a glass material, it is difficult to be deformed by the gripping force of the user, and the container part 11 itself The tip of the rayon swab in the container part 11 cannot be squeezed by deforming. Therefore, it is not preferable to use the rayon swab that requires the work of squeezing the tip to increase the recovery rate in the sugar chain antigen extraction kit 1 according to the above-described embodiment.

これに対して、フログドスワブ、スポンジスワブ及びループの3種類の検体採取用スワブは、先端部分を単に内壁に押し当てるだけでも、BSAの回収率が非常に高いことから、従来のような先端部分をしごく作業が不要となる。従って、上述した実施の形態による糖鎖抗原抽出キット1では、採取部6の表面に立毛表層部7が設けられた検体採取用スワブ2(フログトスワブ)だけでなく、スポンジスワブやループを用いても、気密容器3内において検体抽出液S内に検体を抽出させて、余分な検体抽出液S等が検体採取用スワブに吸われることなく、より多くの試液を生成できる。   On the other hand, the three types of sample collection swabs, Frog Swab, Sponge Swab and Loop, have a very high BSA recovery rate by simply pressing the tip against the inner wall. No need for squeezing work. Therefore, in the sugar chain antigen extraction kit 1 according to the above-described embodiment, not only the sample collection swab 2 (Frog swab) in which the napped surface layer portion 7 is provided on the surface of the collection unit 6, but also a sponge swab or loop can be used. The sample can be extracted into the sample extract S in the airtight container 3, and more sample solution can be generated without the excess sample extract S or the like being sucked into the sample collection swab.

(3-3)容器部内の検体抽出液の液量について
次に、容器部11内に封入する検体抽出液Sの液量について検証する。ここでは、容器部11の内径が異なる11種類の気密容器3を用意し、各容器部11について、容器部11内の液高と液量との関係について調べたところ、下記の表3のような結果が得られた。
(3-3) About the amount of the sample extract in the container Next, the amount of the sample extract S sealed in the container 11 is verified. Here, eleven kinds of hermetic containers 3 having different inner diameters of the container parts 11 were prepared, and the relation between the liquid height and the liquid amount in the container parts 11 was examined for each container part 11, as shown in Table 3 below. Results were obtained.

Figure 0006182526
Figure 0006182526

ここで、糖鎖抗原抽出キット1において、検体採取用スワブ2の採取部6にて採取した検体を検体抽出液Sに抽出させるためには、検体採取用スワブ2の採取部6が検体抽出液Sに浸る必要がある。この糖鎖抗原抽出キット1にて用いる検体採取用スワブ2には、採取部6の先端から約3[mm]の付近に採取部6の最大の膨らみ部分が形成されていると仮定する。この場合、採取部6の最大の膨らみ部分を検体抽出液Sに浸すことを考えると、検体抽出液Sの液高としては3[mm]以上とすることが好ましい。   Here, in the sugar chain antigen extraction kit 1, in order to extract the sample collected by the collection unit 6 of the sample collection swab 2 into the sample extraction solution S, the collection unit 6 of the sample collection swab 2 uses the sample extraction solution. It is necessary to immerse in S. In the sample collection swab 2 used in this sugar chain antigen extraction kit 1, it is assumed that the maximum bulge portion of the collection unit 6 is formed in the vicinity of about 3 [mm] from the tip of the collection unit 6. In this case, considering that the maximum bulge portion of the collection unit 6 is immersed in the sample extract S, the liquid height of the sample extract S is preferably 3 mm or more.

そこで、用意した11種類の容器部11毎にそれぞれ検体抽出液Sの液高が3[mm]以上となる液量を調べた結果、表3に示すような結果が得られ、表3から各容器部11を用いる際に好ましい液量を決定することができる。なお、従来から用いられていた柔らかい抽出用チューブ100(図9A)であれば、指で抽出用チューブを潰すことで全体に検体抽出液Sを行き渡らせて絞ることができるが、本発明によるガラス材料からなる容器部11では、容器部11を潰すことが困難であるものの、容器部11内に液高3[mm]の検体抽出液Sがあれば、容器部11自体を斜めに傾けることで、検体採取用スワブ2の採取部6を検体抽出液Sにほぼ浸して検体を抽出することができる。   Therefore, as a result of examining the liquid volume at which the liquid height of the specimen extract S was 3 [mm] or more for each of the 11 kinds of prepared container parts 11, the results shown in Table 3 were obtained. A preferable liquid amount can be determined when the container part 11 is used. In the case of the soft extraction tube 100 (FIG. 9A) that has been used conventionally, the sample extract S can be distributed and squeezed by crushing the extraction tube with a finger, but the glass according to the present invention. Although it is difficult to crush the container part 11 made of a material, if the specimen extract S having a liquid height of 3 [mm] is contained in the container part 11, the container part 11 itself can be tilted obliquely. The specimen can be extracted by substantially immersing the collection portion 6 of the specimen collection swab 2 in the specimen extract S.

ここで、ガラス材料でなる容器部11では、検体抽出液Sに浸した後に検体採取用スワブ2が取り出される際、検体採取用スワブ2の採取部6に吸着し検体抽出液Sを効率良く絞ることができない。その一方で、本発明の糖鎖抗原抽出キット1を構成する検体採取用スワブ2は、採取部6の表面に立毛表層部7が形成されており、採取部6にて検体抽出液Sを多く吸うことなく、表面の立毛表層部7にて毛細管現象や表面張力で検体抽出液Sを保持するだけであることから、その分、採取部6にて保持される検体抽出液Sの液量が約50[μL]程度と少なくなる。その結果、容器部11には、1回の検査に使用する検体抽出液Sとして、50〜200[μL/test]の液量の検体抽出液Sが封入されていればよい。   Here, in the container portion 11 made of a glass material, when the sample collection swab 2 is taken out after being immersed in the sample extract S, the sample extract S is adsorbed to the collection portion 6 of the sample collection swab 2 to efficiently squeeze the sample extract S. I can't. On the other hand, the sample collection swab 2 constituting the sugar chain antigen extraction kit 1 of the present invention has the napped surface layer portion 7 formed on the surface of the collection unit 6, and the sample extraction solution S is increased in the collection unit 6. Since the sample extract S is only held by capillary action or surface tension at the surface raised surface layer portion 7 of the surface without sucking, the amount of the sample extract S held by the sampling portion 6 is accordingly increased. It will decrease to about 50 [μL]. As a result, it is only necessary that the specimen extract S with a liquid amount of 50 to 200 [μL / test] be enclosed in the container 11 as the specimen extract S used for one test.

なお、従来のA群β溶血連鎖球菌抗原キットにて用いるレイヨンスワブたる綿棒105(図9B)は、吸収量が200[μL]と大きいため、抽出用チューブ100に最低350[μL]の液量でなる検体抽出液を貯留させる必要がある。また、この綿棒105は、長い間、抽出したり、抽出用チューブ100の側壁に強く押し付ける等して揉みほぐすと、先端綿球部105aのレイヨンの巻が緩み、形が崩れ膨れるため、より含水量が増える傾向がある。その場合には、検体抽出液の液量をさらに増やしておく必要がある。   The rayon swab cotton swab 105 (FIG. 9B) used in the conventional group A β-hemolytic streptococcal antigen kit has a large absorption amount of 200 [μL], and therefore the extraction tube 100 has a minimum amount of 350 [μL]. It is necessary to store the specimen extract consisting of Also, if this cotton swab 105 is extracted for a long time, or if it is strongly pressed against the side wall of the tube 100 for extraction, etc., the rayon winding of the tip cotton ball part 105a loosens and the shape collapses and swells. Tend to increase. In that case, it is necessary to further increase the amount of the specimen extract.

これに対して、本発明の糖鎖抗原抽出キット1では、上述したように、検体採取用スワブ2の採取部6にて保持される液量が約50[μL]程度と少ないことから、1回の検査に使用する検体抽出液Sとして、50〜200[μL/test]の検体抽出液Sが気密容器に封入されていればよく、従来のA群β溶血連鎖球菌抗原キットよりも検体抽出液Sの液量を格段的に減らすことができる。   In contrast, in the sugar chain antigen extraction kit 1 of the present invention, as described above, the amount of liquid retained in the collection unit 6 of the sample collection swab 2 is as small as about 50 [μL]. 50 to 200 [μL / test] sample extract S should be enclosed in an airtight container as the sample extract S used for each test, and sample extraction is better than the conventional group A β-hemolytic streptococcal antigen kit. The amount of the liquid S can be significantly reduced.

なお、上記の表3に示す内径は、容器部11の底部の内径を示す。容器部11の開口部13は底部よりも小さい場合が多いが、これに限らず、検体採取用スワブの採取部の大きさに合わせて、開口部13が採取部6の挿入可能な口径に選定すればよい。例えば検体採取用スワブ2の先端にある採取部6の最大径が5[mm]程度ある場合には、容器部11の開口部13の口径が5[mm]以上必要となり、より好ましくは7[mm]以上の口径が好ましい。   The inner diameter shown in Table 3 above indicates the inner diameter of the bottom of the container portion 11. The opening 13 of the container part 11 is often smaller than the bottom part, but this is not a limitation, and the opening 13 is selected as the diameter that the sampling part 6 can be inserted according to the size of the sampling part of the sample collection swab. do it. For example, when the maximum diameter of the collection part 6 at the tip of the specimen collection swab 2 is about 5 [mm], the diameter of the opening 13 of the container part 11 needs to be 5 [mm] or more, more preferably 7 [ mm] or more is preferable.

(4)他の実施の形態
(4-1)他の実施の形態による気密容器の構成
なお、本発明は、上述した実施の形態に限定されるものではなく、本発明の要旨の範囲内で種々の変形実施が可能であり、気密性を維持し得れば、種々の構成の気密容器を適用してもよく、例えば、図1との対応部分に同一符号を付して示す図5のように、キャップ21の天板部21aに貫通孔22を設け、当該貫通孔22をパッキン24にて閉塞した気密容器20を適用してもよい。この場合でも、気密容器20では、キャップ21を開放させるまで気密性を維持することで、例えば6か月以上、好ましくは12か月以上の長期間に亘って、検体抽出液Sが持つA群β溶血連鎖球菌抗原の抽出能力を保持し得るようになされている。
(4) Other Embodiments (4-1) Structure of an Airtight Container According to Other Embodiments The present invention is not limited to the above-described embodiments, and is within the scope of the gist of the present invention. As long as various modifications can be made and the airtightness can be maintained, airtight containers having various configurations may be applied. For example, in FIG. As described above, the airtight container 20 in which the through hole 22 is provided in the top plate portion 21a of the cap 21 and the through hole 22 is closed by the packing 24 may be applied. Even in this case, in the airtight container 20, by maintaining the airtightness until the cap 21 is opened, for example, a group A of the sample extract S over a long period of 6 months or longer, preferably 12 months or longer. The ability to extract β-hemolytic streptococcal antigen can be maintained.

実際上、この気密容器20は、図2との対応部分に同一符号を付して示す図6のように、キャップ21の天板部21aの中央領域に穿設された貫通孔22を塞ぐようにして、当該天板部21aの裏面にパッキン24が配置され得る。この場合、パッキン24は、天板部21aの裏面に合わせた外郭形状でなり、所定の厚みがある円盤状に形成されており、キャップ21の貫通孔22の気密性を維持し得るようになされている。   In practice, the hermetic container 20 covers the through hole 22 formed in the central region of the top plate portion 21a of the cap 21, as shown in FIG. Thus, the packing 24 can be disposed on the back surface of the top plate portion 21a. In this case, the packing 24 has an outer shape matching the back surface of the top plate portion 21a, is formed in a disk shape having a predetermined thickness, and can maintain the airtightness of the through hole 22 of the cap 21. ing.

因みに、この実施の形態の場合でも、上述した実施の形態と同様の樹脂部材によってパッキン24を形成することが望ましく、好ましくは温度25℃において窒素ガス透過係数が4.8[ml・cm/cm2・sec・cmHg]以下、より好ましくは気密性の高いブチルゴムの窒素ガス透過係数(25[℃]で0.247[ml・cm/cm2・sec・cmHg])以下の樹脂部材によってパッキン24を形成することが望ましい。Incidentally, even in the case of this embodiment, it is desirable to form the packing 24 by a resin member similar to that of the above-described embodiment, and preferably at a temperature of 25 ° C., the nitrogen gas permeability coefficient is 4.8 [ml · cm / cm 2 · The packing 24 is formed of a resin member of sec · cmHg] or less, more preferably a nitrogen gas permeation coefficient of butyl rubber having high airtightness (0.247 [ml · cm / cm 2 · sec · cmHg] at 25 ° C) or less. Is desirable.

なお、このキャップは、天板部21aの周縁部から筒部21bが垂下しており、当該筒部21bの内周面に雌ねじ17が形成され、雌ねじ17が容器部11の雄ねじ15と螺着し得る。この気密容器20では、キャップ21を外すことなく、例えば検体採取用スワブ2(図1)の軸部5の他方先端などを用いて、キャップ21の貫通孔22から露出したパッキン24を破り、当該貫通孔22から検体採取用スワブ2の採取部6を容器部11内に挿入することもできる。   In this cap, the cylindrical portion 21b hangs down from the peripheral edge of the top plate portion 21a, the female screw 17 is formed on the inner peripheral surface of the cylindrical portion 21b, and the female screw 17 is screwed to the male screw 15 of the container portion 11. Can do. In this airtight container 20, without removing the cap 21, the packing 24 exposed from the through hole 22 of the cap 21 is broken using, for example, the other end of the shaft portion 5 of the sample collection swab 2 (FIG. 1). The collection part 6 of the sample collection swab 2 can also be inserted into the container part 11 from the through hole 22.

また、他の実施の形態による気密容器としては、図7に示すように、容器部31の開口部13の周縁側壁部にキャップ32が螺着されることなく、単に覆うようにして固着され、容器部31内の気密性が維持されている気密容器30でもよい。   Further, as an airtight container according to another embodiment, as shown in FIG. 7, the cap 32 is not screwed to the peripheral side wall portion of the opening portion 13 of the container portion 31, and is simply fixed so as to cover it. The airtight container 30 in which the airtightness in the container part 31 is maintained may be used.

この場合、キャップ32は、容器部31の開口部13に嵌合される栓体34と、栓体34が嵌合された開口部13の上部及び周辺側壁部全体を覆うプロテクター35と、プロテクター35の上部にて当該プロテクター35と止着され、プロテクター35及び栓体34を覆うカバー部36とで構成されている。   In this case, the cap 32 includes a plug 34 fitted into the opening 13 of the container 31, a protector 35 covering the upper part of the opening 13 into which the plug 34 is fitted and the entire peripheral side wall, and a protector 35. The cover 35 is fixed to the protector 35 at an upper portion of the cover 35 and covers the protector 35 and the plug 34.

実際上、この実施の形態の場合、栓体34は、例えばブチルゴムや、エラストマ、EVAなどの樹脂材料を成形することにより、半硬質又は軟質な可撓性部材として形成され、開口部13に嵌め込まれることで、容器部31の気密性を維持し得る。なお、この実施の形態の場合、栓体34は、円筒部が開口部13の内壁に沿って密着するようにして嵌合し、上部にて開口部13全体を覆い、気密性を維持し得るようになされている。   In practice, in the case of this embodiment, the plug 34 is formed as a semi-rigid or soft flexible member by molding a resin material such as butyl rubber, elastomer, EVA, etc., and is fitted into the opening 13. As a result, the air tightness of the container part 31 can be maintained. In the case of this embodiment, the plug body 34 is fitted so that the cylindrical portion is in close contact with the inner wall of the opening portion 13, and covers the entire opening portion 13 at the upper portion, so that airtightness can be maintained. It is made like that.

栓体34を覆うプロテクター35は、アルミ材などでなり、開口部13の周縁側壁部に形成された、かぶら部31aから栓体34までを全て覆い、開口部13と栓体34との密封性を向上し得るようになされている。この実施の形態の場合、プロテクター35は、裾部が巻締機により巻締められて、傾斜したかぶら部31aに沿って密着するように形成され、密封性を一段と向上し得るようになされている。   The protector 35 that covers the plug body 34 is made of an aluminum material or the like, covers the entire area from the wall 31a to the plug body 34 formed on the peripheral side wall portion of the opening section 13, and seals between the opening section 13 and the plug body 34. Has been made to improve. In the case of this embodiment, the protector 35 is formed so that the skirt portion is tightened by a tightening machine and is in close contact with the inclined fogged portion 31a, so that the sealing performance can be further improved. .

カバー部36は、天板部36aの裏面に設けた突起部42と、裏面との間に破断部41が形成されており、プロテクター35への装着時、当該プロテクター35の開口縁部39と、破断部41とが一体成型されている。すなわち、カバー部36は、プロテクター35への装着時、プロテクター35から離されるような上方への外力が加わると、プロテクター35の開口縁部39に一体成型された破断部41が破断して開口縁部39から切り離され、プロテクター35から外されるようになされている。   The cover part 36 is formed with a rupture part 41 between the protrusion part 42 provided on the back surface of the top plate part 36a and the back surface, and when attached to the protector 35, an opening edge 39 of the protector 35, The fracture portion 41 is integrally molded. That is, when the cover part 36 is attached to the protector 35 and an external force upward is applied so as to be separated from the protector 35, the break part 41 integrally formed with the opening edge part 39 of the protector 35 is broken and the opening edge is broken. It is separated from the part 39 and removed from the protector 35.

このような気密容器30では、カバー部36を外した後、プロテクター35及び栓体34を外すことなく、例えば検体採取用スワブ2の軸部5の他方先端などで、プロテクター35から露出した栓体34の中央領域を破り、検体採取用スワブ2の採取部6を容器部31内に挿入することもできる。   In such an airtight container 30, after removing the cover portion 36, the plug body exposed from the protector 35, for example, at the other end of the shaft portion 5 of the sample collection swab 2 without removing the protector 35 and the plug body 34. It is also possible to break the central region of 34 and insert the collection part 6 of the sample collection swab 2 into the container part 31.

そして、このような気密容器30であっても、キャップ32を開放させるまで容器部31内の気密性を維持し得、例えば6か月以上、好ましくは12か月以上の長期間に亘って、検体抽出液Sが持つA群β溶血連鎖球菌抗原の抽出能力を保持し得るようになされている。   And even in such an airtight container 30, it is possible to maintain the airtightness in the container part 31 until the cap 32 is opened, for example, for 6 months or more, preferably over a long period of 12 months or more, The sample extract S can maintain the ability to extract group A β-hemolytic streptococcal antigens.

(4-2)他の実施の形態による粉状体を入れた気密容器の構成
上述した実施の形態においては、気密容器3内に検体抽出液Sだけを封入させるようにした場合について述べたが、本発明はこれに限らず、図1との対応部分に同一符号を付して示す図8のように、検体抽出液Sとともにガラスビーズ等の粉状体(しごき部材)51を気密容器50内に封入させるようにしてもよい。このように、検体抽出液Sとともに粉状体51を気密容器50内に入れた場合には、検体採取用スワブ2(図1)の採取部6を容器部11内の検体抽出液Sに浸した際、当該採取部6を粉状体51中に埋もらせて擦ることができる。
(4-2) Configuration of an airtight container containing a powder according to another embodiment In the above-described embodiment, the case where only the specimen extract S is sealed in the airtight container 3 has been described. The present invention is not limited to this, and as shown in FIG. 8 in which the same reference numerals are assigned to the corresponding parts to FIG. 1, a powdery substance (squeezing member) 51 such as a glass bead together with the specimen extract S is sealed in an airtight container 50. You may make it enclose in. Thus, when the powdery substance 51 is put in the airtight container 50 together with the specimen extract S, the collection section 6 of the specimen collection swab 2 (FIG. 1) is immersed in the specimen extract S in the container section 11. In this case, the sampling part 6 can be buried in the powder 51 and rubbed.

これにより、粉状体51が入れられた気密容器50では、立毛表層部7を採取部6に設けた検体採取用スワブ2だけでなく、通常用いられるレイヨンスワブたる綿棒105(図9B)であっても、綿棒105の先端綿球部105aを容器部11から引き抜く際に、容器部11の外側から先端綿球部105aを絞ることができなくとも、当該先端綿球部105aを粉状体51間に埋め込む等して擦ることにより、その衝撃によって先端綿球部105aに浸透した検体を検体抽出液に抽出させることができる。すなわち、綿棒105でも、気密容器50内の粉状体51(所定部位)に採取部6を押し付けることで採取部6から検体抽出液に検体を抽出させることができる。   Thus, in the airtight container 50 in which the powdery body 51 is placed, not only the sample collection swab 2 provided with the napped surface layer portion 7 in the collection unit 6 but also a cotton swab 105 (FIG. 9B) which is a commonly used rayon swab. Even if the tip cotton ball 105a cannot be squeezed from the outside of the container part 11 when the tip cotton ball part 105a of the cotton swab 105 is pulled out from the container part 11, the tip cotton ball part 105a is removed from the powdery body 51. By rubbing by embedding in between, the specimen that has penetrated into the tip cotton ball part 105a by the impact can be extracted into the specimen extract. That is, even with the cotton swab 105, the sample can be extracted from the collection unit 6 into the sample extract by pressing the collection unit 6 against the powder 51 (predetermined site) in the airtight container 50.

ここで、このような気密容器50の容器部11内に設けられるしごき部材としては、上述したガラスビーズの他、プラスチックビーズ、アルミナ、砂などの鉱物ビーズ、セラミックビーズ、プラスティックなどその他種々の粉状体を適用してもよい。また、他のしごき部材としては、例えば円筒状パッキンを容器部11の開口部13に設け、円筒状パッキンの筒部に検体採取用スワブの先端部分を出し入れすることで、容器部11内にて筒部の先端に先端部分を当ててしごくなど、種々のしごき部材を適用してもよく、要は検体のついた検体採取用スワブの先端部分が当たるしごき部材を容器部11内に設け、当該しごき部材により検体採取用スワブの先端部分をしごいて、検体を効率よく検体抽出液に抽出することができればよい。   Here, as the ironing member provided in the container portion 11 of the hermetic container 50, in addition to the glass beads described above, various other powders such as plastic beads, mineral beads such as alumina and sand, ceramic beads, and plastics. The body may be applied. Further, as another ironing member, for example, a cylindrical packing is provided in the opening 13 of the container part 11, and the tip portion of the sample collection swab is taken in and out of the cylindrical part of the cylindrical packing, so that the inside of the container part 11 Various ironing members may be applied, such as ironing the tip of the tube portion against the tip of the tube portion.In short, the ironing member that contacts the tip of the sample collection swab with the sample is provided in the container portion 11, and It is only necessary that the tip of the sample collection swab is squeezed by the squeezing member so that the sample can be efficiently extracted into the sample extract.

因みに、粉状体としては、検体採取用スワブの先端部分を検体抽出液S内にて粉状体51と接触させてしごいた後、検体採取用スワブを容器部内から引き出す際、表面張力により検体採取用スワブの先端部分に粉状体が付着しない大きさの粉状体が好ましい。   By the way, as for the powdery body, after the tip part of the sample collection swab is brought into contact with the powdery body 51 in the sample extract S, the surface tension is applied when the sample collection swab is pulled out from the container part. A powdery material having a size such that the powdery material does not adhere to the tip of the sample collecting swab is preferable.

次に、複数種類の粉状体を用意して、容器部に入れた各粉状体によって、綿棒たる咽頭用レイヨンスワブに吸わせたBSAを、どの程度回収できるかについて検証を行った。ここでは、下記の表4に示すように、粉状体を容器部内に入れなかった場合(「BEADSなし」)の他、直径4[mm]のガラスビーズ(「BEADS4」)と、直径3[mm]のガラスビーズ(「BEADS3」)と、直径2[mm]のガラスビーズ(「BEADS2」)と、直径1[mm]のガラスビーズ(「BEADS1」)と、直径0.8[mm]のガラスビーズ(「BEADS0.8」)と、大きさが1[mm]のセラミック粒子(「セラミック」)の6種類の硬質な粉状体を用意した。   Next, a plurality of types of powdery bodies were prepared, and it was verified how much BSA sucked by the rayon swab for pharynx as a cotton swab can be collected by each powdery body placed in the container. Here, as shown in Table 4 below, in addition to the case where the powder was not placed in the container (“without BEADS”), glass beads with a diameter of 4 [mm] (“BEADS4”) and a diameter of 3 [ mm] glass beads ("BEADS3"), 2 [mm] diameter glass beads ("BEADS2"), 1 [mm] diameter glass beads ("BEADS1"), and 0.8 [mm] diameter glass beads ("BEADS0.8") and 6 types of hard powders of 1 [mm] ceramic particles ("ceramic") were prepared.

Figure 0006182526
Figure 0006182526

なお、「BEADS4」〜「BEADS0.8」の各ガラスビーズは、それぞれアズワン株式会社から購入した。コントロール(「Control」)は、ガラスバイアル(外径14[mm]、全高30[mm])に蒸留水を0.6[ml]入れたものに、10[mg/ml]のBSA水溶液を100[μL]加えて、その吸光度(OD280nm)を3回測定した。BSAの吸光係数を0.584として、その数字から濃度を求め、ガラスバイアル(容器部)あたりの量に換算しそれを100[%]回収とした。   The glass beads “BEADS4” to “BEADS0.8” were purchased from As One Corporation. Control ("Control") is a glass vial (outer diameter 14 [mm], total height 30 [mm]) containing distilled water 0.6 [ml], 10 [mg / ml] BSA aqueous solution 100 [μL In addition, the absorbance (OD280nm) was measured three times. The BSA extinction coefficient was set to 0.584, the concentration was determined from the number, converted to the amount per glass vial (container part), and used as 100 [%] recovery.

BEADSなしでは、先ず初めに、10[mg/ml]のBSA水溶液を、咽頭用レイヨンスワブ(平和メディック)に100[μL]吸わせた。次いで、蒸留水が0.6[ml]入ったガラスビーズの入っていないガラスバイアルの内壁に、咽頭用レイヨンスワブを10回押し当てるように回し、咽頭用レイヨンスワブからBSAを蒸留水に抽出した。   Without BEADS, first, 10 [mg / ml] BSA aqueous solution was inhaled by 100 [μL] to the throat rayon swab (Heiwa Medic). Next, the pharyngeal rayon swab was rotated 10 times against the inner wall of a glass vial containing 0.6 [ml] of distilled water without glass beads, and BSA was extracted into distilled water from the throat rayon swab.

綿BSAを含まない検体採取用スワブで、10回抽出操作を行い、Blankとして回収で得られた吸光度の値から引いて補正を行った。また、「BEADS4」〜「BEADS0.8」、「セラミック」についても同様の操作を行い、回収率を換算し求めたところ、表4に示すような結果が得られた。   Extraction was performed 10 times with a sample-collecting swab containing no cotton BSA, and correction was performed by subtracting from the absorbance value obtained by collection as a blank. In addition, the same operation was performed for “BEADS4” to “BEADS0.8” and “ceramic”, and the recovery rate was calculated. The results shown in Table 4 were obtained.

表4から、各粒径のガラスビーズと、セラミック粒子とを用いた結果、ガラスバイアル(容器部)に何も入れないでBSAの回収作業を行うと、BSAの回収率が10[%]以下であるのに対し、ガラスビーズやセラミック粒子等の不反応の抵抗物をガラスバイアルに入れたときには、BSAの回収率が79[%]以上となり、明らかに高い回収効率を示した。このような結果から、不反応性の抵抗物として各種成形品を容器部内に入れることによって、検体採取用スワブとして、従来から用いていた検体を吸収してしまうレイヨンスワブを用いた場合であっても、レイヨンスワブを成形品によりしごくことで、当該レイヨンスワブに吸収された検体を効率よく抽出できることが確認できた。   From Table 4, as a result of using glass beads of various particle sizes and ceramic particles, the recovery rate of BSA is 10% or less when the BSA recovery operation is performed without putting anything in the glass vial (container). On the other hand, when unreacted resistors such as glass beads and ceramic particles were placed in the glass vial, the BSA recovery rate was 79% or more, which clearly showed a high recovery efficiency. From such a result, it is a case where a rayon swab that absorbs a sample that has been used conventionally is used as a sample collection swab by putting various molded products into the container as an unreactive resistor. In addition, it was confirmed that the specimen absorbed by the rayon swab can be efficiently extracted by squeezing the rayon swab with a molded product.

なお、上述した実施の形態においては、検出対象物としてA群β溶血連鎖球菌抗原を適用した場合について述べた、本発明はこれに限らず、種々の抗原を検出対象物として適用してもよい。また、上述した実施の形態による検体キット1おいては、毛細管現象や表面張力により立毛表層部7に検体が留まり吸着し得る検体採取用スワブ2を適用した場合について述べたが、本発明はこれに限らず、少なくとも毛細管現象又は表面張力のいずれか一方により採取部の表面に検体が付着し得る検体採取用スワブを適用してもよい。   In the above-described embodiment, the case where the group A β-hemolytic streptococcal antigen is applied as the detection target is not limited to this, and various antigens may be applied as the detection target. . Further, in the sample kit 1 according to the above-described embodiment, the case where the sample collecting swab 2 that can retain and adsorb the sample on the napped surface layer portion 7 due to capillary action or surface tension has been described, but the present invention describes this. Not limited to this, a sample collection swab that allows the sample to adhere to the surface of the collection part by at least one of capillary action or surface tension may be applied.

また、上述した実施の形態においては、気密容器3と検体採取用スワブ2とを備えた糖鎖抗原抽出キット1について説明したが、本発明はこれに限らず、気密容器3と検体採取用スワブ2とを備えた糖鎖抗原抽出キット1に、A群β溶血連鎖球菌を検出するためのイムノクロマト法用テストストリップを加えた検出キットとしてもよい。   In the above-described embodiment, the sugar chain antigen extraction kit 1 provided with the airtight container 3 and the sample collection swab 2 has been described. However, the present invention is not limited to this, and the airtight container 3 and the sample collection swab are provided. 2 may be used as a detection kit in which an immunochromatographic test strip for detecting group A β-hemolytic streptococci is added to the sugar chain antigen extraction kit 1 provided with 2.

さらに、上述した実施の形態においては、容器部3の開口部にパッキン18を間に挟んでキャップ10を締めつけることで、開口部における気密性を維持する気密容器3を適用した場合について述べたが、本発明はこれに限らず、開口部における気密性が維持できれば、例えばパッキンを介さずに容器部の開口部に直接キャップを締めつける気密容器を適用してもよい。なお、キャップ10は、フェノール樹脂等の硬質な合成樹脂部材で形成することが望ましいが、硬質ガラス等のガラス材料や、その他種々の材料で形成してもよい。また、キャップは、容器部内の気密性が維持できればその形状についても種々の形状としても良く、例えばシート状に形成し、容器部の開口部に貼着する構成としてもよい。   Furthermore, in the above-described embodiment, the case where the airtight container 3 that maintains the airtightness in the opening by applying the packing 10 to the opening of the container 3 and tightening the cap 10 has been described. The present invention is not limited to this, and an airtight container in which a cap is directly fastened to the opening of the container without using a packing may be applied as long as the airtightness in the opening can be maintained. The cap 10 is preferably formed of a hard synthetic resin member such as a phenol resin, but may be formed of a glass material such as hard glass or other various materials. In addition, the cap may have various shapes as long as the airtightness in the container portion can be maintained. For example, the cap may be formed in a sheet shape and attached to the opening of the container portion.

さらに、上述した実施の形態においては、容器部3の開口部を閉塞し、容器部3内の気密性を維持させるキャップ10を、容器部3の開口部に着脱自在に設けるようにした場合について述べたが、本発明はこれに限らず、気密容器内の気密性を維持できれば、例えば、容器部よりも胴体径が小さい頭部が、頭部および容器部よりも胴体径が小さい絞り部を介して容器部の開口部に一体成形されたアンプル型の気密容器を適用しても良い。   Further, in the above-described embodiment, the cap 10 that closes the opening of the container 3 and maintains the airtightness in the container 3 is detachably provided in the opening of the container 3. As described above, the present invention is not limited to this, and if the airtightness in the airtight container can be maintained, for example, a head having a body diameter smaller than the container part has a throttle part having a body diameter smaller than that of the head part and the container part. An ampoule-type airtight container integrally formed in the opening of the container portion may be applied.

このように、頭部が絞り部を介して容器部に一体形成されたアンプル型の気密容器でも、容器部内の気密性を維持し得、従来不可能であった亜硝酸を含ませた状態での検体抽出液の長期保存が可能となり、上述した実施の形態と同様の効果を得ることができる。なお、このような気密容器では、使用時、頭部に外力を与えることで絞り部を破損させて、容器部の開口部を外部に開放し得、容器部内の検体抽出液に検体採取用スワブの先端を浸漬させることができる。因みに、このような頭部が絞り部を介して容器部に一体形成されたアンプル型の気密容器としては、例えば硬質ガラス等のガラス材料により一体形成されることが望ましいが、容器部内の気密性を維持できれば、その他種々の材料により一体形成してもよい。   In this way, even in an ampoule-type airtight container whose head is integrally formed with the container part through the throttle part, the airtightness in the container part can be maintained, and in a state in which nitrous acid has been included, which was impossible in the past The specimen extract can be stored for a long period of time, and the same effects as those of the above-described embodiment can be obtained. In such an airtight container, during use, an external force can be applied to the head to break the throttle, and the opening of the container can be opened to the outside, and the sample collection swab can be added to the sample extract in the container. The tip can be immersed. Incidentally, as an ampoule type airtight container in which such a head is integrally formed with the container part through the throttle part, it is desirable to be formed integrally with a glass material such as hard glass, but the airtightness in the container part is preferable. May be integrally formed of various other materials.

Claims (7)

気密性を維持した容器部内に、亜硝酸を含む検体抽出液が予め封入された気密容器と、
被検者から検体を採取する採取部を備え、前記採取部にて前記検体を採取した後、該採取部が前記検体抽出液に浸され、前記採取部から前記検体抽出液に前記検体を抽出させる検体採取用スワブと
を備え
前記採取部は、開封された前記気密容器内で前記検体抽出液に浸され、
前記被検者から前記検体を採取した際、前記検体が前記採取部の内部にまで浸透することなく、少なくとも毛細管現象又は表面張力のいずれか一方により前記検体を付着させる表面を有し、かつ、前記検体抽出液に浸された後、前記容器部から取り出される際、前記容器部の内壁に押し当てられるだけで、前記検体を前記検体抽出液に放出する
ことを特徴とする糖鎖抗原抽出キット。
An airtight container in which a specimen extract containing nitrous acid is sealed in advance in a container part that maintains airtightness;
A collection unit for collecting a sample from a subject, and after collecting the sample by the collection unit, the collection unit is immersed in the sample extract, and the sample is extracted from the collection unit to the sample extract and a swab for specimen collection to,
The collection unit is immersed in the specimen extract in the opened airtight container,
When the sample is collected from the subject, the sample does not penetrate into the inside of the collection unit, and has a surface to which the sample is attached by at least one of capillary action or surface tension, and A sugar chain antigen extraction kit , wherein the specimen is released into the specimen extract simply by being pressed against the inner wall of the container when being taken out from the container after being immersed in the specimen extract .
気密性を維持した容器部内に、亜硝酸を含む検体抽出液が予め封入された気密容器と、An airtight container in which a specimen extract containing nitrous acid is sealed in advance in a container part that maintains airtightness;
被検者から検体を採取する採取部を備え、前記採取部にて前記検体を採取した後、該採取部が前記検体抽出液に浸され、前記採取部から前記検体抽出液に前記検体を抽出させる検体採取用スワブとA collection unit for collecting a sample from a subject, and after collecting the sample by the collection unit, the collection unit is immersed in the sample extract, and the sample is extracted from the collection unit to the sample extract Swab for sample collection
を備え、With
前記採取部は、開封された前記気密容器内で前記検体抽出液に浸され、The collection unit is immersed in the specimen extract in the opened airtight container,
前記検体採取用スワブが、立毛表層部により覆われた前記採取部を備えたフログドスワブ、表面に多孔質を有したスポンジからなる前記採取部を備えたスポンジスワブ、又は、ループ状に折り曲げられO状に形成された前記採取部を備えるループであるThe sample collection swab is a fluged swab provided with the collection part covered by a napped surface layer part, a sponge swab provided with the collection part made of a sponge having a porous surface, or an O-shape folded in a loop shape It is a loop comprising the sampling part formed in
ことを特徴とする糖鎖抗原抽出キット。A sugar chain antigen extraction kit.
前記気密容器は、気密性を維持した状態で前記検体抽出液を保存し続けることで、前記検体抽出液が持つ検出対象物の抽出能力を、少なくとも6か月以上持続させる
ことを特徴とする請求項1又は2記載の糖鎖抗原抽出キット。
The airtight container, by while maintaining the airtightness continue to store the sample extract, the extraction ability of the detection object to the specimen extract has a feature that is on persistent least 6 months or more The sugar chain antigen extraction kit according to claim 1 or 2 .
前記容器部は、該容器部内の気体が外部に漏れ出ない気密性を備えた硬質材料により形成されている
ことを特徴とする請求項1〜3のうちいずれか1項記載の糖鎖抗原抽出キット。
The sugar chain antigen extraction according to any one of claims 1 to 3, wherein the container part is formed of a hard material having airtightness that prevents gas in the container part from leaking to the outside. kit.
前記気密容器は、前記容器部の開口部にパッキンを間に挟んでキャップが締めつけられることで、該開口部における気密性が維持されている
ことを特徴とする請求項1〜のうちいずれか1項記載の糖鎖抗原抽出キット。
The airtight container in the cap is tightened in between the packing in the opening of the container portion, any one of claims 1-4, characterized in that air-tightness of the opening is maintained 2. The sugar chain antigen extraction kit according to 1.
前記容器部には、前記検体採取用スワブの採取部が前記容器部の内部に挿通された際、該採取部と当たるしごき部材が設けられている
ことを特徴とする請求項1〜のうちいずれか1項記載の糖鎖抗原抽出キット。
To the container portion, when the sampling part of swab the specimen collection is inserted inside the container portion, of the claims 1-5, characterized in that the squeezing member hits with the sampling unit is provided The sugar chain antigen extraction kit according to any one of claims.
請求項1〜6のうちいずれか1項記載の糖鎖抗原抽出キットと、
A群β溶血連鎖球菌を検出するためのイムノクロマト法用テストストリップと
を備えることを特徴とする検出キット。
The sugar chain antigen extraction kit according to any one of claims 1 to 6,
A detection kit comprising an immunochromatographic test strip for detecting group A β-hemolytic streptococci.
JP2014519996A 2012-06-04 2013-06-04 Sugar chain antigen extraction kit and detection kit Expired - Fee Related JP6182526B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014519996A JP6182526B2 (en) 2012-06-04 2013-06-04 Sugar chain antigen extraction kit and detection kit

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012127544 2012-06-04
JP2012127544 2012-06-04
PCT/JP2013/065444 WO2013183621A1 (en) 2012-06-04 2013-06-04 Carbohydrate antigen extraction kit and detection kit
JP2014519996A JP6182526B2 (en) 2012-06-04 2013-06-04 Sugar chain antigen extraction kit and detection kit

Publications (2)

Publication Number Publication Date
JPWO2013183621A1 JPWO2013183621A1 (en) 2016-02-01
JP6182526B2 true JP6182526B2 (en) 2017-08-16

Family

ID=49712012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014519996A Expired - Fee Related JP6182526B2 (en) 2012-06-04 2013-06-04 Sugar chain antigen extraction kit and detection kit

Country Status (2)

Country Link
JP (1) JP6182526B2 (en)
WO (1) WO2013183621A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6476705B2 (en) * 2014-10-02 2019-03-06 東洋紡株式会社 Pretreatment method for antigen detection
EP3324185B1 (en) * 2015-07-16 2020-11-18 Tanaka Kikinzoku Kogyo K.K. Immunoassay and immunochromatographic kit
JP7344540B2 (en) * 2019-06-19 2023-09-14 株式会社Icst Test equipment and methods
CN113985027A (en) * 2021-10-30 2022-01-28 济南百博生物技术股份有限公司 Saliva collecting and splitting system suitable for novel coronavirus antigen self-test

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093546A (en) * 1992-09-03 2000-07-25 Roche Diagnostics Process for preparing test elements
JP2000152777A (en) * 1998-11-18 2000-06-06 Yukitaka Furukawa Biological specimen sampler
AUPP915799A0 (en) * 1999-03-11 1999-04-15 Enterix Inc. Sample collection and testing system
EP1196775A2 (en) * 1999-05-24 2002-04-17 Abbott Laboratories Apparatus for pretreating a sample containing an analyte
US20080254550A1 (en) * 2007-02-05 2008-10-16 Andrew Homer Nathaniel Drug detection kit and method
US20090030342A1 (en) * 2007-07-27 2009-01-29 3M Innovative Properties Company Apparatus and method for releasing a sample of material
CN102216751A (en) * 2008-11-17 2011-10-12 皇家飞利浦电子股份有限公司 A device for collecting a biological fluid sample
JP5584287B2 (en) * 2009-05-14 2014-09-03 ディーエヌエー ジェノテック インク Lid, container, and sampling method

Also Published As

Publication number Publication date
JPWO2013183621A1 (en) 2016-02-01
WO2013183621A1 (en) 2013-12-12

Similar Documents

Publication Publication Date Title
US20100140116A1 (en) Resealable container for storing moisture sensitive test elements
JP6182526B2 (en) Sugar chain antigen extraction kit and detection kit
US6780160B2 (en) Specimen collection and application apparatus
CN103797350B (en) Oral liquid sample collection kit and related method thereof
CN1969184B (en) Specimen collecting, processing and analytical assembly
US6921370B2 (en) Specimen collection and storage and transport device and method
US20100089181A1 (en) Sample Collection System and Method for Use Thereof
US20120226183A1 (en) Evacuated air chamber
US20040171173A1 (en) Device for collecting liquid samples
US20130209993A1 (en) Sample collection system and method for use thereof
KR960033400A (en) Oral fluid sample collection device for home use and package for mailing of this device
US20110204084A1 (en) Sample Collection System and Method for Use Thereof
CA2761718A1 (en) Closure, containing apparatus, and method of using same
US20110294152A1 (en) Calibration material delivery devices and methods
US20160151781A1 (en) Microtube cap
KR102483098B1 (en) Sample insertion type diagnostic kit
US20090162940A1 (en) Specimen Analysis Tube
JP4609252B2 (en) Sample collection liquid container
JP3107824U (en) Sample detection extraction container
CN209624396U (en) A kind of test strips protective case
TWI252918B (en) Simplified analyzing device and method for manufacturing the same
JPH06148178A (en) Living body sample collecting vessel for inspection
CN214694184U (en) Integrated container for nucleic acid detection, sampling and sample adding
US1718590A (en) Blood-extracting device
CN211453651U (en) Enterovirus 71 IgM antibody detection kit

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170110

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20170307

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170307

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170509

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170704

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170724

R150 Certificate of patent or registration of utility model

Ref document number: 6182526

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees